<?xml version='1.0' encoding='UTF-8'?>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">PLoS Biol</journal-id>
      <journal-id journal-id-type="iso-abbrev">PLoS Biol</journal-id>
      <journal-id journal-id-type="publisher-id">plos</journal-id>
      <journal-id journal-id-type="pmc">plosbiol</journal-id>
      <journal-title-group>
        <journal-title>PLoS Biology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1544-9173</issn>
      <issn pub-type="epub">1545-7885</issn>
      <publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, CA USA</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">33284797</article-id>
      <article-id pub-id-type="pmc">7721148</article-id>
      <article-id pub-id-type="doi">10.1371/journal.pbio.3000966</article-id>
      <article-id pub-id-type="publisher-id">PBIOLOGY-D-20-01040</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Medicine and Health Sciences</subject>
          <subj-group>
            <subject>Mental Health and Psychiatry</subject>
            <subj-group>
              <subject>Mood Disorders</subject>
              <subj-group>
                <subject>Depression</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Computer and Information Sciences</subject>
          <subj-group>
            <subject>Neural Networks</subject>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Biology and Life Sciences</subject>
          <subj-group>
            <subject>Neuroscience</subject>
            <subj-group>
              <subject>Neural Networks</subject>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Research and Analysis Methods</subject>
          <subj-group>
            <subject>Imaging Techniques</subject>
            <subj-group>
              <subject>Neuroimaging</subject>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Biology and Life Sciences</subject>
          <subj-group>
            <subject>Neuroscience</subject>
            <subj-group>
              <subject>Neuroimaging</subject>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Computer and Information Sciences</subject>
          <subj-group>
            <subject>Data Acquisition</subject>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Physical Sciences</subject>
          <subj-group>
            <subject>Mathematics</subject>
            <subj-group>
              <subject>Discrete Mathematics</subject>
              <subj-group>
                <subject>Combinatorics</subject>
                <subj-group>
                  <subject>Permutation</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Physical Sciences</subject>
          <subj-group>
            <subject>Mathematics</subject>
            <subj-group>
              <subject>Applied Mathematics</subject>
              <subj-group>
                <subject>Algorithms</subject>
                <subj-group>
                  <subject>Machine Learning Algorithms</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Research and Analysis Methods</subject>
          <subj-group>
            <subject>Simulation and Modeling</subject>
            <subj-group>
              <subject>Algorithms</subject>
              <subj-group>
                <subject>Machine Learning Algorithms</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Computer and Information Sciences</subject>
          <subj-group>
            <subject>Artificial Intelligence</subject>
            <subj-group>
              <subject>Machine Learning</subject>
              <subj-group>
                <subject>Machine Learning Algorithms</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Research and Analysis Methods</subject>
          <subj-group>
            <subject>Imaging Techniques</subject>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Biology and Life Sciences</subject>
          <subj-group>
            <subject>Neuroscience</subject>
            <subj-group>
              <subject>Brain Mapping</subject>
              <subj-group>
                <subject>Functional Magnetic Resonance Imaging</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Medicine and Health Sciences</subject>
          <subj-group>
            <subject>Diagnostic Medicine</subject>
            <subj-group>
              <subject>Diagnostic Radiology</subject>
              <subj-group>
                <subject>Magnetic Resonance Imaging</subject>
                <subj-group>
                  <subject>Functional Magnetic Resonance Imaging</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Research and Analysis Methods</subject>
          <subj-group>
            <subject>Imaging Techniques</subject>
            <subj-group>
              <subject>Diagnostic Radiology</subject>
              <subj-group>
                <subject>Magnetic Resonance Imaging</subject>
                <subj-group>
                  <subject>Functional Magnetic Resonance Imaging</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Medicine and Health Sciences</subject>
          <subj-group>
            <subject>Radiology and Imaging</subject>
            <subj-group>
              <subject>Diagnostic Radiology</subject>
              <subj-group>
                <subject>Magnetic Resonance Imaging</subject>
                <subj-group>
                  <subject>Functional Magnetic Resonance Imaging</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Research and Analysis Methods</subject>
          <subj-group>
            <subject>Imaging Techniques</subject>
            <subj-group>
              <subject>Neuroimaging</subject>
              <subj-group>
                <subject>Functional Magnetic Resonance Imaging</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v3">
          <subject>Biology and Life Sciences</subject>
          <subj-group>
            <subject>Neuroscience</subject>
            <subj-group>
              <subject>Neuroimaging</subject>
              <subj-group>
                <subject>Functional Magnetic Resonance Imaging</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Generalizable brain network markers of major depressive disorder across multiple imaging sites</article-title>
        <alt-title alt-title-type="running-head">Brain network markers of depression</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3825-2919</contrib-id>
          <name>
            <surname>Yamashita</surname>
            <given-names>Ayumu</given-names>
          </name>
          <role content-type="https://casrai.org/credit/">Conceptualization</role>
          <role content-type="https://casrai.org/credit/">Formal analysis</role>
          <role content-type="https://casrai.org/credit/">Investigation</role>
          <role content-type="https://casrai.org/credit/">Methodology</role>
          <role content-type="https://casrai.org/credit/">Software</role>
          <role content-type="https://casrai.org/credit/">Visualization</role>
          <role content-type="https://casrai.org/credit/">Writing – original draft</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="cor001">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2475-8548</contrib-id>
          <name>
            <surname>Sakai</surname>
            <given-names>Yuki</given-names>
          </name>
          <role content-type="https://casrai.org/credit/">Methodology</role>
          <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3664-947X</contrib-id>
          <name>
            <surname>Yamada</surname>
            <given-names>Takashi</given-names>
          </name>
          <role content-type="https://casrai.org/credit/">Data curation</role>
          <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff002">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yahata</surname>
            <given-names>Noriaki</given-names>
          </name>
          <role content-type="https://casrai.org/credit/">Data curation</role>
          <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff003">
            <sup>3</sup>
          </xref>
          <xref ref-type="aff" rid="aff004">
            <sup>4</sup>
          </xref>
          <xref ref-type="aff" rid="aff005">
            <sup>5</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kunimatsu</surname>
            <given-names>Akira</given-names>
          </name>
          <role content-type="https://casrai.org/credit/">Data curation</role>
          <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
          <xref ref-type="aff" rid="aff006">
            <sup>6</sup>
          </xref>
          <xref ref-type="aff" rid="aff007">
            <sup>7</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Okada</surname>
            <given-names>Naohiro</given-names>
          </name>
          <role content-type="https://casrai.org/credit/">Data curation</role>
          <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
          <xref ref-type="aff" rid="aff003">
            <sup>3</sup>
          </xref>
          <xref ref-type="aff" rid="aff008">
            <sup>8</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Itahashi</surname>
            <given-names>Takashi</given-names>
          </name>
          <role content-type="https://casrai.org/credit/">Data curation</role>
          <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
          <xref ref-type="aff" rid="aff002">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9661-3412</contrib-id>
          <name>
            <surname>Hashimoto</surname>
            <given-names>Ryuichiro</given-names>
          </name>
          <role content-type="https://casrai.org/credit/">Data curation</role>
          <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff002">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff009">
            <sup>9</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mizuta</surname>
            <given-names>Hiroto</given-names>
          </name>
          <role content-type="https://casrai.org/credit/">Data curation</role>
          <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
          <xref ref-type="aff" rid="aff010">
            <sup>10</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ichikawa</surname>
            <given-names>Naho</given-names>
          </name>
          <role content-type="https://casrai.org/credit/">Data curation</role>
          <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
          <xref ref-type="aff" rid="aff011">
            <sup>11</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9742-152X</contrib-id>
          <name>
            <surname>Takamura</surname>
            <given-names>Masahiro</given-names>
          </name>
          <role content-type="https://casrai.org/credit/">Data curation</role>
          <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
          <xref ref-type="aff" rid="aff011">
            <sup>11</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Okada</surname>
            <given-names>Go</given-names>
          </name>
          <role content-type="https://casrai.org/credit/">Data curation</role>
          <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
          <xref ref-type="aff" rid="aff011">
            <sup>11</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yamagata</surname>
            <given-names>Hirotaka</given-names>
          </name>
          <role content-type="https://casrai.org/credit/">Data curation</role>
          <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
          <xref ref-type="aff" rid="aff012">
            <sup>12</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Harada</surname>
            <given-names>Kenichiro</given-names>
          </name>
          <role content-type="https://casrai.org/credit/">Data curation</role>
          <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
          <xref ref-type="aff" rid="aff012">
            <sup>12</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2002-5526</contrib-id>
          <name>
            <surname>Matsuo</surname>
            <given-names>Koji</given-names>
          </name>
          <role content-type="https://casrai.org/credit/">Data curation</role>
          <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
          <xref ref-type="aff" rid="aff012">
            <sup>12</sup>
          </xref>
          <xref ref-type="aff" rid="aff013">
            <sup>13</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7001-5051</contrib-id>
          <name>
            <surname>Tanaka</surname>
            <given-names>Saori C.</given-names>
          </name>
          <role content-type="https://casrai.org/credit/">Data curation</role>
          <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8185-1197</contrib-id>
          <name>
            <surname>Kawato</surname>
            <given-names>Mitsuo</given-names>
          </name>
          <role content-type="https://casrai.org/credit/">Conceptualization</role>
          <role content-type="https://casrai.org/credit/">Funding acquisition</role>
          <role content-type="https://casrai.org/credit/">Project administration</role>
          <role content-type="https://casrai.org/credit/">Supervision</role>
          <role content-type="https://casrai.org/credit/">Writing – original draft</role>
          <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff014">
            <sup>14</sup>
          </xref>
          <xref ref-type="corresp" rid="cor001">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4443-4535</contrib-id>
          <name>
            <surname>Kasai</surname>
            <given-names>Kiyoto</given-names>
          </name>
          <role content-type="https://casrai.org/credit/">Data curation</role>
          <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff003">
            <sup>3</sup>
          </xref>
          <xref ref-type="aff" rid="aff008">
            <sup>8</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kato</surname>
            <given-names>Nobumasa</given-names>
          </name>
          <role content-type="https://casrai.org/credit/">Data curation</role>
          <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff002">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Takahashi</surname>
            <given-names>Hidehiko</given-names>
          </name>
          <role content-type="https://casrai.org/credit/">Data curation</role>
          <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
          <xref ref-type="aff" rid="aff010">
            <sup>10</sup>
          </xref>
          <xref ref-type="aff" rid="aff015">
            <sup>15</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Okamoto</surname>
            <given-names>Yasumasa</given-names>
          </name>
          <role content-type="https://casrai.org/credit/">Data curation</role>
          <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
          <xref ref-type="aff" rid="aff011">
            <sup>11</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6039-3657</contrib-id>
          <name>
            <surname>Yamashita</surname>
            <given-names>Okito</given-names>
          </name>
          <role content-type="https://casrai.org/credit/">Methodology</role>
          <role content-type="https://casrai.org/credit/">Writing – original draft</role>
          <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff014">
            <sup>14</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1024-0051</contrib-id>
          <name>
            <surname>Imamizu</surname>
            <given-names>Hiroshi</given-names>
          </name>
          <role content-type="https://casrai.org/credit/">Conceptualization</role>
          <role content-type="https://casrai.org/credit/">Funding acquisition</role>
          <role content-type="https://casrai.org/credit/">Supervision</role>
          <role content-type="https://casrai.org/credit/">Writing – original draft</role>
          <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff016">
            <sup>16</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff001"><label>1</label>
<addr-line>Brain Information Communication Research Laboratory Group, Advanced Telecommunications Research Institutes International, Kyoto, Japan</addr-line></aff>
      <aff id="aff002"><label>2</label>
<addr-line>Medical Institute of Developmental Disabilities Research, Showa University, Tokyo, Japan</addr-line></aff>
      <aff id="aff003"><label>3</label>
<addr-line>Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan</addr-line></aff>
      <aff id="aff004"><label>4</label>
<addr-line>Institute for Quantum Life Science, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan</addr-line></aff>
      <aff id="aff005"><label>5</label>
<addr-line>Department of Molecular Imaging and Theranostics, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan</addr-line></aff>
      <aff id="aff006"><label>6</label>
<addr-line>Department of Radiology, IMSUT Hospital, Institute of Medical Science, The University of Tokyo, Tokyo, Japan</addr-line></aff>
      <aff id="aff007"><label>7</label>
<addr-line>Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan</addr-line></aff>
      <aff id="aff008"><label>8</label>
<addr-line>The International Research Center for Neurointelligence (WPI-IRCN) at the University of Tokyo Institutes for Advanced Study (UTIAS), Tokyo, Japan</addr-line></aff>
      <aff id="aff009"><label>9</label>
<addr-line>Department of Language Sciences, Tokyo Metropolitan University, Tokyo, Japan</addr-line></aff>
      <aff id="aff010"><label>10</label>
<addr-line>Department of Psychiatry, Kyoto University Graduate School of Medicine, Kyoto, Japan</addr-line></aff>
      <aff id="aff011"><label>11</label>
<addr-line>Department of Psychiatry and Neurosciences, Hiroshima University, Hiroshima, Japan</addr-line></aff>
      <aff id="aff012"><label>12</label>
<addr-line>Division of Neuropsychiatry, Department of Neuroscience, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan</addr-line></aff>
      <aff id="aff013"><label>13</label>
<addr-line>Department of Psychiatry, Faculty of Medicine, Saitama Medical University, Saitama, Japan</addr-line></aff>
      <aff id="aff014"><label>14</label>
<addr-line>Center for Advanced Intelligence Project, RIKEN, Tokyo, Japan</addr-line></aff>
      <aff id="aff015"><label>15</label>
<addr-line>Department of Psychiatry and Behavioral Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan</addr-line></aff>
      <aff id="aff016"><label>16</label>
<addr-line>Department of Psychology, Graduate School of Humanities and Sociology, The University of Tokyo, Tokyo, Japan</addr-line></aff>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Wager</surname>
            <given-names>Tor D.</given-names>
          </name>
          <role>Academic Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group>
      <aff id="edit1">
        <addr-line>Darmouth College, UNITED STATES</addr-line>
      </aff>
      <author-notes>
        <fn fn-type="COI-statement" id="coi001">
          <p>I have read the journal's policy and the authors of this manuscript have the following competing interests: M.K., N.Y., R.H., H.I., N.K. and K.K are inventors of a patent owned by Advanced Telecommunications Research (ATR) Institute International related to the present work [PCT/JP2014/061543 (WO2014178322)]. M.K., N.Y., R.H., N.K. and K.K. are inventors of a patent owned by ATR Institute International related to the present work [PCT/JP2014/061544 (WO2014178323)]. M.K. and N.Y. are inventors of a patent application submitted by ATR Institute International related to the present work [JP2015-228970]. A.Y. and M.K. are inventors of a patent application submitted by ATR Institute International related to the present work [JP2018-192842].</p>
        </fn>
        <corresp id="cor001">* E-mail: <email>ayumu@atr.jp</email> (AY); <email>kawato@atr.jp</email> (MK)</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>7</day>
        <month>12</month>
        <year>2020</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>12</month>
        <year>2020</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>7</day>
        <month>12</month>
        <year>2020</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
      <volume>18</volume>
      <issue>12</issue>
      <elocation-id>e3000966</elocation-id>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>4</month>
          <year>2020</year>
        </date>
        <date date-type="accepted">
          <day>2</day>
          <month>11</month>
          <year>2020</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2020 Yamashita et al</copyright-statement>
        <copyright-year>2020</copyright-year>
        <copyright-holder>Yamashita et al</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:href="pbio.3000966.pdf"/>
      <abstract>
        <p>Many studies have highlighted the difficulty inherent to the clinical application of fundamental neuroscience knowledge based on machine learning techniques. It is difficult to generalize machine learning brain markers to the data acquired from independent imaging sites, mainly due to large site differences in functional magnetic resonance imaging. We address the difficulty of finding a generalizable marker of major depressive disorder (MDD) that would distinguish patients from healthy controls based on resting-state functional connectivity patterns. For the discovery dataset with 713 participants from 4 imaging sites, we removed site differences using our recently developed harmonization method and developed a machine learning MDD classifier. The classifier achieved an approximately 70% generalization accuracy for an independent validation dataset with 521 participants from 5 different imaging sites. The successful generalization to a perfectly independent dataset acquired from multiple imaging sites is novel and ensures scientific reproducibility and clinical applicability.</p>
      </abstract>
      <abstract abstract-type="toc">
        <p>Biomarkers for psychiatric disorders based on neuroimaging data have yet to be put to practical use. This study overcomes the problems of inter-site differences in fMRI data by using a novel harmonization method, thereby successfully constructing a generalizable brain network marker of major depressive disorder across multiple imaging sites.</p>
      </abstract>
      <funding-group>
        <award-group id="award001">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100009619</institution-id>
              <institution>Japan Agency for Medical Research and Development</institution>
            </institution-wrap>
          </funding-source>
          <award-id>JP18dm0307008</award-id>
          <principal-award-recipient>
            <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8185-1197</contrib-id>
            <name>
              <surname>Kawato</surname>
              <given-names>Mitsuo</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group id="award002">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100009619</institution-id>
              <institution>Japan Agency for Medical Research and Development</institution>
            </institution-wrap>
          </funding-source>
          <award-id>JP18dm0307001</award-id>
          <principal-award-recipient>
            <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8185-1197</contrib-id>
            <name>
              <surname>Kawato</surname>
              <given-names>Mitsuo</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group id="award003">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100009619</institution-id>
              <institution>Japan Agency for Medical Research and Development</institution>
            </institution-wrap>
          </funding-source>
          <award-id>JP18dm0307004</award-id>
          <principal-award-recipient>
            <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8185-1197</contrib-id>
            <name>
              <surname>Kawato</surname>
              <given-names>Mitsuo</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group id="award004">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100009619</institution-id>
              <institution>Japan Agency for Medical Research and Development</institution>
            </institution-wrap>
          </funding-source>
          <award-id>JP19dm0307009</award-id>
          <principal-award-recipient>
            <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8185-1197</contrib-id>
            <name>
              <surname>Kawato</surname>
              <given-names>Mitsuo</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group id="award005">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001691</institution-id>
              <institution>Japan Society for the Promotion of Science</institution>
            </institution-wrap>
          </funding-source>
          <award-id>16H06280</award-id>
          <principal-award-recipient>
            <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8185-1197</contrib-id>
            <name>
              <surname>Kawato</surname>
              <given-names>Mitsuo</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group id="award006">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001691</institution-id>
              <institution>Japan Society for the Promotion of Science</institution>
            </institution-wrap>
          </funding-source>
          <award-id>18H01098</award-id>
          <principal-award-recipient>
            <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1024-0051</contrib-id>
            <name>
              <surname>Imamizu</surname>
              <given-names>Hiroshi</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group id="award007">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001691</institution-id>
              <institution>Japan Society for the Promotion of Science</institution>
            </institution-wrap>
          </funding-source>
          <award-id>18H05302</award-id>
          <principal-award-recipient>
            <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1024-0051</contrib-id>
            <name>
              <surname>Imamizu</surname>
              <given-names>Hiroshi</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group id="award008">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001691</institution-id>
              <institution>Japan Society for the Promotion of Science</institution>
            </institution-wrap>
          </funding-source>
          <award-id>19H05725</award-id>
          <principal-award-recipient>
            <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1024-0051</contrib-id>
            <name>
              <surname>Imamizu</surname>
              <given-names>Hiroshi</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <funding-statement>This study was conducted under the contract research "Brain/MINDS Beyond" Grant Number JP18dm0307008, supported by the Japan Agency for Medical Research and Development (AMED) while using data obtained from the database project supported by“Development of BMI Technologies for Clinical Application” of the Strategic Research Program for Brain Sciences JP17dm0107044 (AMED). This study was also supported by Grant Number JP18dm0307002, JP18dm0307004, and JP19dm0307009 (AMED). M.K., H.I. and A.Y. were partially supported by the ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan). K.K. was partially supported by the International Research Center for Neurointelligence (WPI-IRCN) at The University of Tokyo Institutes for Advanced Study (UTIAS) and JSPS KAKENHI 16H06280 (Advanced Bioimaging Support). H.I. was partially supported by JSPS KAKENHI 18H01098, 18H05302, and 19H05725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
      </funding-group>
      <counts>
        <fig-count count="5"/>
        <table-count count="1"/>
        <page-count count="26"/>
      </counts>
      <custom-meta-group>
        <custom-meta id="data-availability">
          <meta-name>Data Availability</meta-name>
          <meta-value>Relevant data which used in the figures are within its <xref ref-type="sec" rid="sec023">Supporting Information</xref> files. The raw data utilized in this study can be downloaded publicly from the DecNef Project Brain Data Repository at <ext-link ext-link-type="uri" xlink:href="https://bicr-resource.atr.jp/srpbsopen/">https://bicr-resource.atr.jp/srpbsopen/</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://bicr.atr.jp/dcn/en/download/harmonization/">https://bicr.atr.jp/dcn/en/download/harmonization/</ext-link>.</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
    <notes>
      <title>Data Availability</title>
      <p>Relevant data which used in the figures are within its <xref ref-type="sec" rid="sec023">Supporting Information</xref> files. The raw data utilized in this study can be downloaded publicly from the DecNef Project Brain Data Repository at <ext-link ext-link-type="uri" xlink:href="https://bicr-resource.atr.jp/srpbsopen/">https://bicr-resource.atr.jp/srpbsopen/</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://bicr.atr.jp/dcn/en/download/harmonization/">https://bicr.atr.jp/dcn/en/download/harmonization/</ext-link>.</p>
    </notes>
  </front>
  <body>
    <sec sec-type="intro" id="sec001">
      <title>Introduction</title>
      <p>Major depressive disorder (MDD) is a highly heterogeneous psychiatric disorder, and a lumping approach that treats MDD as a single entity has been criticized since early 2000 [<xref rid="pbio.3000966.ref001" ref-type="bibr">1</xref>,<xref rid="pbio.3000966.ref002" ref-type="bibr">2</xref>]. Such heterogeneity in psychiatric disorders has motivated the Research Domain Criteria (RDoC) initiative, which aims to redefine and identify subtypes of psychiatric disorders in terms of biological systems, without relying on a diagnosis based solely on symptoms and signs [<xref rid="pbio.3000966.ref003" ref-type="bibr">3</xref>]. This initiative is expected to inform our understanding of heterogeneous and overlapping clinical presentations of psychotic disorders [<xref rid="pbio.3000966.ref004" ref-type="bibr">4</xref>–<xref rid="pbio.3000966.ref007" ref-type="bibr">7</xref>]. In particular, resting-state functional magnetic resonance imaging (rs-fMRI) is a useful modality to this end because it enables us to noninvasively investigate whole brain functional connectivity (FC) in diverse patient populations [<xref rid="pbio.3000966.ref008" ref-type="bibr">8</xref>,<xref rid="pbio.3000966.ref009" ref-type="bibr">9</xref>]. rs-fMRI allows for the quantification of the FC of correlated, spontaneous blood-oxygen-level–dependent (BOLD) signal fluctuations [<xref rid="pbio.3000966.ref010" ref-type="bibr">10</xref>]. Machine learning algorithms have emerged as powerful tools for the analysis of a large number of FCs (usually between 10,000 and 100,000 for an individual). According to the original idea of the RDoC initiative, subtyping and redefining psychiatric disorders should be based on solely biological and cognitive measurements (FCs in the current context) without relying on traditional symptom-based categories [<xref rid="pbio.3000966.ref011" ref-type="bibr">11</xref>–<xref rid="pbio.3000966.ref013" ref-type="bibr">13</xref>]. An unsupervised learning technique is the first candidate for this data-driven approach. However, the number of explanatory variables, FCs, is huge (10,000 to 100,000), while the sample size, i.e., the number of participants, usually ranges between 100 and 1,000. Thus, overfitting to noise in the data by machine learning algorithms and the resultant inflation of prediction performance can easily occur [<xref rid="pbio.3000966.ref012" ref-type="bibr">12</xref>,<xref rid="pbio.3000966.ref014" ref-type="bibr">14</xref>,<xref rid="pbio.3000966.ref015" ref-type="bibr">15</xref>]. This situation makes it difficult to directly apply an unsupervised learning algorithm to FC data.</p>
      <p>To address this problem and successfully subtype and redefine psychiatric disorders, we proposed the following hierarchical supervised/unsupervised approach, which was shown to have been partially successful in several studies [<xref rid="pbio.3000966.ref016" ref-type="bibr">16</xref>–<xref rid="pbio.3000966.ref018" ref-type="bibr">18</xref>]. First, we identified a relatively small number of FCs that reliably distinguish healthy controls (HCs) and patients with psychiatric disorders using a supervised learning algorithm. Our purpose at this stage is to find potentially relevant biological dimensions to psychiatric disorders. Thus, lumping categories such as “MDD” as a single entity may provide useful information with supervised learning to search for relevant biological dimensions. We can use the identified FCs not only for a brain network biomarker of the psychiatric disorder but also for biologically meaningful dimensions related to the disorder. Second, we applied unsupervised learning to these low biological dimensions to redefine and find subtypes of psychiatric disorders. For instance, we were able to achieve subtyping of MDD by locating patients with MDD in these dimensions [<xref rid="pbio.3000966.ref019" ref-type="bibr">19</xref>]. Furthermore, locating different psychiatric disorders (e.g., MDD, schizophrenia [SCZ], and autism spectrum disorder [ASD]) in these dimensions may reveal the relationships among the disorders (multi-disorder spectrum) [<xref rid="pbio.3000966.ref016" ref-type="bibr">16</xref>–<xref rid="pbio.3000966.ref018" ref-type="bibr">18</xref>]. As such, although our approach starts with supervised learning based on a lumping category such as a diagnosis, such category is only used as a single piece of information to recruit relevant FCs to psychiatric disorders. Our final goal is to understand psychiatric disorders in the biological dimensions while avoiding overfitting to noise in the discovery dataset and ensuring generalization performance for the independent data in completely different multiple imaging sites.</p>
      <p>Whether a brain network marker constructed in the first stage generalizes to the data acquired from multiple completely different imaging sites is a crucial issue for the above hierarchical supervised/unsupervised approach [<xref rid="pbio.3000966.ref020" ref-type="bibr">20</xref>–<xref rid="pbio.3000966.ref022" ref-type="bibr">22</xref>]. However, an increasing number of studies have highlighted the difficulty in generalization of the brain network marker to the data acquired from multiple completely independent imaging sites, even using the supervised learning method [<xref rid="pbio.3000966.ref014" ref-type="bibr">14</xref>,<xref rid="pbio.3000966.ref023" ref-type="bibr">23</xref>]. For example, in a recent paper by Drysdale, which is one of the most successful brain network markers of MDD, the classification accuracy for MDD in completely independent imaging sites was 68.8% for 16 patients from 1 site, which represents only 3% of the validation cohort ([<xref rid="pbio.3000966.ref012" ref-type="bibr">12</xref>]).</p>
      <p>Here, we targeted MDD, the world’s most serious psychiatric disorder in terms of its social repercussions [<xref rid="pbio.3000966.ref024" ref-type="bibr">24</xref>,<xref rid="pbio.3000966.ref025" ref-type="bibr">25</xref>]. To achieve the final goal (redefinition and subtyping), it is an absolutely necessary prerequisite to first treat MDD as a single entity using diagnoses as supervised data and create the brain network marker that generalizes to a completely independent data collected from multiple imaging sites. We considered and satisfied 3 issues and conditions to ensure generalization of our network marker of MDD to the independent validation dataset, which does not include imaging sites of the discovery dataset. First, we used our recently developed harmonization method, which could reduce site differences in FC [<xref rid="pbio.3000966.ref026" ref-type="bibr">26</xref>]. According to our recent study, the differences in resting-state FCs for different imaging sites consist of measurement bias due to differences in fMRI protocols and MR scanners and sampling bias due to recruitment of different participant populations. The magnitude of the measurement bias was larger than the effects of disorders including MDD, and the magnitude of the sampling bias was comparable with the effects of disorders [<xref rid="pbio.3000966.ref026" ref-type="bibr">26</xref>]. Therefore, a reduction in the site difference in FC is essential for the generalization of network models in the validation dataset. Second, we validated our network marker using a perfectly independent and large cohort collected from multiple completely different imaging sites. Specifically, for constructing a brain network marker, we used an rs-fMRI discovery dataset with 713 participants (149 patients with MDD) from 4 imaging sites (Center of Innovation in Hiroshima University (COI), Kyoto University (KUT), Showa University (SWA), and University of Tokyo (UTO)). This discovery dataset was collected by a Japanese nationwide database project called the Strategic Research Program for Brain Science (SRPBS, <ext-link ext-link-type="uri" xlink:href="https://bicr.atr.jp/decnefpro/">https://bicr.atr.jp/decnefpro/</ext-link>) since 2014. After constructing the brain network marker, we examined generalization of the network marker to an independent validation dataset with 449 participants (185 patients with MDD) from 4 different imaging sites (Hiroshima Kajikawa Hospital [HKH], Hiroshima Rehabilitation Center [HRC], Hiroshima University Hospital [HUH], and Yamaguchi University [UYA]). This validation dataset was formed after the construction of the network marker and was acquired for other projects since 2008 independently of the SRPBS. We further assessed the generalization performance to the data collected from a country other than Japan by using publicly available rs-fMRI dataset with 72 participants (51 patients with MDD) from OpenNeuro (<ext-link ext-link-type="uri" xlink:href="https://openneuro.org/datasets/ds002748/versions/1.0.0">https://openneuro.org/datasets/ds002748/versions/1.0.0</ext-link>). Furthermore, we used another dataset of 75 HCs, 154 patients with SCZ, and 121 patients with ASD to investigate the multi-disorder spectrum. In total, we used 1,584 participants’ data in this study. Furthermore, unlike previous studies that restricted the subtype of MDD [<xref rid="pbio.3000966.ref012" ref-type="bibr">12</xref>,<xref rid="pbio.3000966.ref016" ref-type="bibr">16</xref>], we targeted all patients with MDD without restricting according to the depression subtype in order to enable future subtyping in the biological dimensions, which is beyond the purpose of the current paper. Third, we carefully avoided overfitting noise in the discovery dataset. As explained above, the number of explanatory variables is typically larger than the sample size in the rs-fMRI study; thus, overfitting to noise in the discovery dataset by machine learning algorithms and resultant inflation of prediction performance can happen easily unless special precautions are taken. We used a sparse machine learning algorithm with the least absolute shrinkage and selection operator (LASSO) to avoid overfitting to noise and selected only essential FCs [<xref rid="pbio.3000966.ref027" ref-type="bibr">27</xref>]. As a result, for the first time, to our knowledge, we developed a generalizable brain network marker for MDD without restricting to certain subtypes such as treatment-resistant or melancholic MDD.</p>
      <p>Previous studies have shown that a diagnosis of MDD based on the Diagnostic and Statistical Manual of Mental Disorders (DSM) has a low inter-rater agreement (kappa = 0.28) [<xref rid="pbio.3000966.ref028" ref-type="bibr">28</xref>,<xref rid="pbio.3000966.ref029" ref-type="bibr">29</xref>]. In this study, we have developed a brain network marker that can objectively predict a diagnosis from structured interviews, which have relatively high inter-rater agreement, such as the Structured Clinical Interview for DSM (SCID) (kappa = 0.64~0.74) [<xref rid="pbio.3000966.ref030" ref-type="bibr">30</xref>,<xref rid="pbio.3000966.ref031" ref-type="bibr">31</xref>] or the Mini-International Neuropsychiatric Interview (high agreement with SCID: kappa = 0.85) [<xref rid="pbio.3000966.ref032" ref-type="bibr">32</xref>]. To objectively compare and verify the stability of the diagnoses based on DSM and brain FC, we performed a simulation. Our simulation will show that our brain network marker of MDD may more objectively and stably diagnose MDD than a diagnosis based on DSM even if we considered the variance across multiple scans, different fMRI scanners, and different imaging sites. Of note, although previous studies suggest that it is especially difficult to make a diagnosis that differentiates MDD from bipolar disorder [<xref rid="pbio.3000966.ref033" ref-type="bibr">33</xref>], it is relatively straightforward for an experienced clinician to distinguish between MDD and healthy status in clinical practice. Therefore, the utility of the rs-fMRI-based brain network marker is to understand underlying pathophysiological mechanisms of the illness and to guide treatment choice and the future development of novel interventions for a given disorder.</p>
    </sec>
    <sec sec-type="results" id="sec002">
      <title>Results</title>
      <sec id="sec003">
        <title>Datasets</title>
        <p>We used 2 rs-fMRI datasets for the analyses. The “discovery dataset” contained data from 713 participants (564 HCs from 4 sites, 149 patients with MDD from 3 sites; <xref rid="pbio.3000966.t001" ref-type="table">Table 1</xref>), and the “independent validation dataset” contained data from 521 participants (285 HCs and 236 patients with MDD from 5 independent sites; <xref rid="pbio.3000966.t001" ref-type="table">Table 1</xref>). Most data utilized in this study can be downloaded publicly from the DecNef Project Brain Data Repository (<ext-link ext-link-type="uri" xlink:href="https://bicr-resource.atr.jp/srpbsopen/">https://bicr-resource.atr.jp/srpbsopen/</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://bicr.atr.jp/dcn/en/download/harmonization/">https://bicr.atr.jp/dcn/en/download/harmonization/</ext-link>) and OpenNeuro (<ext-link ext-link-type="uri" xlink:href="https://openneuro.org/datasets/ds002748/versions/1.0.0">https://openneuro.org/datasets/ds002748/versions/1.0.0</ext-link>). The imaging protocols and data availability statement of each site is described in <xref ref-type="supplementary-material" rid="pbio.3000966.s013">S1 Table</xref>. Depression symptoms were evaluated using the Beck Depression Inventory-II (BDI-II) score obtained from most participants in each dataset. Clinical details such as medication information and the presence of comorbidities in patients with MDD are described in <xref ref-type="supplementary-material" rid="pbio.3000966.s014">S2 Table</xref>.</p>
        <table-wrap id="pbio.3000966.t001" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pbio.3000966.t001</object-id>
          <label>Table 1</label>
          <caption>
            <title>Demographic characteristics of participants in both datasets.</title>
          </caption>
          <alternatives>
            <graphic id="pbio.3000966.t001g" xlink:href="pbio.3000966.t001"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="center" rowspan="2" colspan="1">Site</th>
                  <th align="center" colspan="4" rowspan="1">HC</th>
                  <th align="center" colspan="4" rowspan="1">MDD</th>
                  <th align="center" colspan="4" rowspan="1">All</th>
                </tr>
                <tr>
                  <th align="center" rowspan="1" colspan="1">Number</th>
                  <th align="center" rowspan="1" colspan="1">Male/Female</th>
                  <th align="center" rowspan="1" colspan="1">Age (y)</th>
                  <th align="center" rowspan="1" colspan="1">BDI</th>
                  <th align="center" rowspan="1" colspan="1">Number</th>
                  <th align="center" rowspan="1" colspan="1">Male/Female</th>
                  <th align="center" rowspan="1" colspan="1">Age (y)</th>
                  <th align="center" rowspan="1" colspan="1">BDI</th>
                  <th align="center" rowspan="1" colspan="1">Number</th>
                  <th align="center" rowspan="1" colspan="1">Male/Female</th>
                  <th align="center" rowspan="1" colspan="1">Age (y)</th>
                  <th align="center" rowspan="1" colspan="1">BDI</th>
                </tr>
              </thead>
              <tbody>
                <tr style="border-top:thick">
                  <td align="center" colspan="13" rowspan="1">
                    <bold>Discovery dataset</bold>
                  </td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Center of Innovation in Hiroshima University<break/>(COI)</td>
                  <td align="center" rowspan="1" colspan="1">124</td>
                  <td align="center" rowspan="1" colspan="1">46/78</td>
                  <td align="center" rowspan="1" colspan="1">51.9 ± 13.4</td>
                  <td align="center" rowspan="1" colspan="1">8.2 ± 6.3</td>
                  <td align="center" rowspan="1" colspan="1">70</td>
                  <td align="center" rowspan="1" colspan="1">31/39</td>
                  <td align="center" rowspan="1" colspan="1">45.0 ± 12.5</td>
                  <td align="center" rowspan="1" colspan="1">26.2 ± 9.9</td>
                  <td align="center" rowspan="1" colspan="1">194</td>
                  <td align="center" rowspan="1" colspan="1">77/117</td>
                  <td align="center" rowspan="1" colspan="1">49.4 ± 13.5</td>
                  <td align="center" rowspan="1" colspan="1">14.7 ± 11.7</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Kyoto University<break/>(KUT)</td>
                  <td align="center" rowspan="1" colspan="1">169</td>
                  <td align="center" rowspan="1" colspan="1">100/69</td>
                  <td align="center" rowspan="1" colspan="1">35.9 ± 13.6</td>
                  <td align="center" rowspan="1" colspan="1">6.0 ± 5.4</td>
                  <td align="center" rowspan="1" colspan="1">17</td>
                  <td align="center" rowspan="1" colspan="1">11/6</td>
                  <td align="center" rowspan="1" colspan="1">43.9 ± 13.3</td>
                  <td align="center" rowspan="1" colspan="1">27.7 ± 10.1</td>
                  <td align="center" rowspan="1" colspan="1">186</td>
                  <td align="center" rowspan="1" colspan="1">111/75</td>
                  <td align="center" rowspan="1" colspan="1">36.7 ± 13.7</td>
                  <td align="center" rowspan="1" colspan="1">8.3 ± 9.1</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Showa University<break/>(SWA)</td>
                  <td align="center" rowspan="1" colspan="1">101</td>
                  <td align="center" rowspan="1" colspan="1">86/15</td>
                  <td align="center" rowspan="1" colspan="1">28.4 ± 7.9</td>
                  <td align="center" rowspan="1" colspan="1">4.4 ± 3.8</td>
                  <td align="center" rowspan="1" colspan="1">0</td>
                  <td align="center" rowspan="1" colspan="1">-</td>
                  <td align="center" rowspan="1" colspan="1">-</td>
                  <td align="center" rowspan="1" colspan="1">-</td>
                  <td align="center" rowspan="1" colspan="1">101</td>
                  <td align="center" rowspan="1" colspan="1">86/15</td>
                  <td align="center" rowspan="1" colspan="1">28.4 ± 7.9</td>
                  <td align="center" rowspan="1" colspan="1">4.4 ± 3.8</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">University of Tokyo<break/>(UTO)</td>
                  <td align="center" rowspan="1" colspan="1">170</td>
                  <td align="center" rowspan="1" colspan="1">78/92</td>
                  <td align="center" rowspan="1" colspan="1">35.6 ± 17.5</td>
                  <td align="center" rowspan="1" colspan="1">6.7 ± 6.5</td>
                  <td align="center" rowspan="1" colspan="1">62</td>
                  <td align="center" rowspan="1" colspan="1">36/26</td>
                  <td align="center" rowspan="1" colspan="1">38.7± 11.6</td>
                  <td align="center" rowspan="1" colspan="1">20.4 ± 11.4</td>
                  <td align="center" rowspan="1" colspan="1">232</td>
                  <td align="center" rowspan="1" colspan="1">114/118</td>
                  <td align="center" rowspan="1" colspan="1">36.4 ± 16.2</td>
                  <td align="center" rowspan="1" colspan="1">14.5 ± 11.8</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Summary</td>
                  <td align="center" rowspan="1" colspan="1">564</td>
                  <td align="center" rowspan="1" colspan="1">310/254</td>
                  <td align="center" rowspan="1" colspan="1">38.0 ± 16.1</td>
                  <td align="center" rowspan="1" colspan="1">6.3 ± 5.6</td>
                  <td align="center" rowspan="1" colspan="1">149</td>
                  <td align="center" rowspan="1" colspan="1">78/71</td>
                  <td align="center" rowspan="1" colspan="1">42.3 ± 12.5</td>
                  <td align="center" rowspan="1" colspan="1">24.9 ± 10.7</td>
                  <td align="center" rowspan="1" colspan="1">713</td>
                  <td align="center" rowspan="1" colspan="1">388/325</td>
                  <td align="center" rowspan="1" colspan="1">38.9 ±15.5</td>
                  <td align="center" rowspan="1" colspan="1">10.7 ± 10.6</td>
                </tr>
                <tr style="border-top:thick">
                  <td align="center" colspan="13" rowspan="1">
                    <bold>Independent validation dataset</bold>
                  </td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Hiroshima Kajikawa Hospital<break/>(HKH)</td>
                  <td align="center" rowspan="1" colspan="1">29</td>
                  <td align="center" rowspan="1" colspan="1">12/17</td>
                  <td align="center" rowspan="1" colspan="1">45.4 ± 9.5</td>
                  <td align="center" rowspan="1" colspan="1">5.1 ± 4.6</td>
                  <td align="center" rowspan="1" colspan="1">33</td>
                  <td align="center" rowspan="1" colspan="1">20/13</td>
                  <td align="center" rowspan="1" colspan="1">44.8 ± 11.5</td>
                  <td align="center" rowspan="1" colspan="1">28.5 ± 8.7</td>
                  <td align="center" rowspan="1" colspan="1">62</td>
                  <td align="center" rowspan="1" colspan="1">32/30</td>
                  <td align="center" rowspan="1" colspan="1">45.1 ± 10.5</td>
                  <td align="center" rowspan="1" colspan="1">17.6 ± 13.7</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Hiroshima Rehabilitation Center<break/>(HRC)</td>
                  <td align="center" rowspan="1" colspan="1">49</td>
                  <td align="center" rowspan="1" colspan="1">13/36</td>
                  <td align="center" rowspan="1" colspan="1">41.7 ± 11.7</td>
                  <td align="center" rowspan="1" colspan="1">9.1 ± 8.5</td>
                  <td align="center" rowspan="1" colspan="1">16</td>
                  <td align="center" rowspan="1" colspan="1">6/10</td>
                  <td align="center" rowspan="1" colspan="1">40.5 ± 11.5</td>
                  <td align="center" rowspan="1" colspan="1">35.3 ± 9.5</td>
                  <td align="center" rowspan="1" colspan="1">65</td>
                  <td align="center" rowspan="1" colspan="1">19/46</td>
                  <td align="center" rowspan="1" colspan="1">41.4 ± 11.5</td>
                  <td align="center" rowspan="1" colspan="1">15.6 ± 14.3</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Hiroshima University Hospital<break/>(HUH)</td>
                  <td align="center" rowspan="1" colspan="1">66</td>
                  <td align="center" rowspan="1" colspan="1">29/37</td>
                  <td align="center" rowspan="1" colspan="1">34.6 ± 13.0</td>
                  <td align="center" rowspan="1" colspan="1">6.9 ± 5.9</td>
                  <td align="center" rowspan="1" colspan="1">57</td>
                  <td align="center" rowspan="1" colspan="1">32/25</td>
                  <td align="center" rowspan="1" colspan="1">43.3 ± 12.2</td>
                  <td align="center" rowspan="1" colspan="1">30.9 ± 9.0</td>
                  <td align="center" rowspan="1" colspan="1">123</td>
                  <td align="center" rowspan="1" colspan="1">61/62</td>
                  <td align="center" rowspan="1" colspan="1">38.6 ± 13.3</td>
                  <td align="center" rowspan="1" colspan="1">18.0 ± 14.1</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Yamaguchi University<break/>(UYA)</td>
                  <td align="center" rowspan="1" colspan="1">120</td>
                  <td align="center" rowspan="1" colspan="1">50/70</td>
                  <td align="center" rowspan="1" colspan="1">45.9 ± 19.5</td>
                  <td align="center" rowspan="1" colspan="1">7.1 ± 5.6</td>
                  <td align="center" rowspan="1" colspan="1">79</td>
                  <td align="center" rowspan="1" colspan="1">36/43</td>
                  <td align="center" rowspan="1" colspan="1">50.3 ± 13.6</td>
                  <td align="center" rowspan="1" colspan="1">29.7 ± 10.7</td>
                  <td align="center" rowspan="1" colspan="1">199</td>
                  <td align="center" rowspan="1" colspan="1">86/113</td>
                  <td align="center" rowspan="1" colspan="1">47.6 ± 17.5</td>
                  <td align="center" rowspan="1" colspan="1">16.0 ± 13.6</td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">Summary</td>
                  <td align="center" rowspan="1" colspan="1">264</td>
                  <td align="center" rowspan="1" colspan="1">104/160</td>
                  <td align="center" rowspan="1" colspan="1">42.2 ± 16.5</td>
                  <td align="center" rowspan="1" colspan="1">7.2 ± 6.3</td>
                  <td align="center" rowspan="1" colspan="1">185</td>
                  <td align="center" rowspan="1" colspan="1">94/91</td>
                  <td align="center" rowspan="1" colspan="1">46.3 ± 13.0</td>
                  <td align="center" rowspan="1" colspan="1">30.3 ± 9.9</td>
                  <td align="center" rowspan="1" colspan="1">449</td>
                  <td align="center" rowspan="1" colspan="1">198/251</td>
                  <td align="center" rowspan="1" colspan="1">43.9 ± 15.3</td>
                  <td align="center" rowspan="1" colspan="1">16.7 ± 13.9</td>
                </tr>
                <tr style="border-top:thick">
                  <td align="center" colspan="13" rowspan="1">
                    <bold>OpenNeuro dataset</bold>
                  </td>
                </tr>
                <tr>
                  <td align="center" rowspan="1" colspan="1">OTHER</td>
                  <td align="center" rowspan="1" colspan="1">21</td>
                  <td align="center" rowspan="1" colspan="1">6/15</td>
                  <td align="center" rowspan="1" colspan="1">33.8±8.49</td>
                  <td align="center" rowspan="1" colspan="1">-</td>
                  <td align="center" rowspan="1" colspan="1">51</td>
                  <td align="center" rowspan="1" colspan="1">13/38</td>
                  <td align="center" rowspan="1" colspan="1">32.7±8.94</td>
                  <td align="center" rowspan="1" colspan="1">-</td>
                  <td align="center" rowspan="1" colspan="1">72</td>
                  <td align="center" rowspan="1" colspan="1">19/53</td>
                  <td align="center" rowspan="1" colspan="1">33.1±8.73</td>
                  <td align="center" rowspan="1" colspan="1">-</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="t001fn001">
              <p>Demographic distribution of sex rate was matched between the MDD and HC populations in the discovery dataset (<italic>P</italic> &gt; 0.05) but not for age or BDI (<italic>P</italic> &lt; 0.05). All demographic distributions were not matched between the MDD and HC populations in the independent validation dataset (<italic>P</italic> &lt; 0.05). The link to OpenNeuro dataset is <ext-link ext-link-type="uri" xlink:href="https://openneuro.org/datasets/ds002748/versions/1.0.0">https://openneuro.org/datasets/ds002748/versions/1.0.0</ext-link></p>
            </fn>
            <fn id="t001fn002">
              <p>BDI, Beck Depression Inventory-II; HC, healthy control; MDD, major depressive disorder.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="sec004">
        <title>Site difference control in FC</title>
        <p>Classical preprocessing was performed, and FC was defined based on a functional brain atlas consisting of 379 nodes (regions) covering the whole brain [<xref rid="pbio.3000966.ref034" ref-type="bibr">34</xref>]. The Fisher’s <italic>z</italic>-transformed Pearson correlation coefficients between the preprocessed BOLD signal time courses of each possible pair of nodes were calculated and used to construct 379 × 379 symmetrical connectivity matrices in which each element represents a connection strength, or edge, between 2 nodes. We used 71,631 connectivity values (379 × 378/2) of the lower triangular matrix of the connectivity matrix. To control for site differences in the FC, we applied a traveling subject harmonization method to the discovery dataset [<xref rid="pbio.3000966.ref026" ref-type="bibr">26</xref>]. In this method, the measurement bias (the influence of the difference in the properties of MRI scanners, such as the imaging parameters, field strength, MRI manufacturer, and scanner model) was estimated by fitting the regression model to the FC values of all participants from the discovery dataset and the traveling subject dataset, wherein multiple participants travel to multiple sites to assess measurement bias (see Control of site differences in the Materials and methods section). This method enabled us to subtract only the measurement bias while leaving important information due to differences in subjects among imaging sites. We applied the ComBat harmonization method [<xref rid="pbio.3000966.ref035" ref-type="bibr">35</xref>–<xref rid="pbio.3000966.ref038" ref-type="bibr">38</xref>] to control for site differences in the FC of the independent validation dataset because we did not have a traveling subject dataset for those sites.</p>
      </sec>
      <sec id="sec005">
        <title>Reproducible FCs related to MDD diagnosis</title>
        <p>Using a simple mass univariate analysis, we first investigated the reproducibility of the effect size by diagnosis on individual FC across the discovery and validation datasets. For the effect of the diagnosis on each FC, we calculated the difference in the FC value between the HCs and the MDDs (<italic>t</italic>-value). <xref ref-type="fig" rid="pbio.3000966.g001">Fig 1</xref> shows the diagnosis effect size for the discovery dataset in the abscissa and that for the validation dataset in the ordinate for each FC. To statistically evaluate the reproducibility of the effect on FCs, we calculated the Pearson’s correlation of the effect sizes (<italic>t</italic>-values) between the discovery and validation datasets. We compared this Pearson’s correlation value with the distributions of the Pearson’s correlation in the shuffled data in which diagnosis labels were permuted across subjects (permutation test). We found a significant correlation between the 2 datasets (<italic>r</italic><sub>(71,631)</sub> = 0.494, 95% confidence interval (CI) = [0.488 0.499], <italic>R</italic><sup>2</sup>
<italic>=</italic> 0.24, [permutation test, <italic>P</italic> &lt; 0.001, 1-sided]). This result indicates that resting-state FCs contain consistent information regarding MDD diagnosis across the 2 datasets, even if the 2 datasets were acquired from completely different sites.</p>
        <fig id="pbio.3000966.g001" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pbio.3000966.g001</object-id>
          <label>Fig 1</label>
          <caption>
            <title>Results of mass univariate analysis.</title>
            <p>Reproducibility across the 2 datasets regarding diagnosis effects. Scatter plot and histograms of the diagnosis effect size (the difference in mean functional connectivity strengths between patients with depression and healthy groups: <italic>t</italic>-value). Each point in the scatter plot represents the diagnosis effect in the discovery dataset in the abscissa and that for the independent validation dataset in the ordinate for each functional connectivity. The original data is in black, while the shuffled data in which subject information was permuted is in gray. The numerical data used in this figure are included in <xref ref-type="supplementary-material" rid="pbio.3000966.s001">S1 Data</xref>.</p>
          </caption>
          <graphic xlink:href="pbio.3000966.g001"/>
        </fig>
      </sec>
      <sec id="sec006">
        <title>Brain network marker of MDD diagnosis generalized to MDD data obtained from completely different multi-sites</title>
        <p>We constructed a brain network marker for MDD, which distinguished between HCs and MDD patients, using the discovery dataset based on 71,631 FC values. Based on our previous studies [<xref rid="pbio.3000966.ref016" ref-type="bibr">16</xref>–<xref rid="pbio.3000966.ref018" ref-type="bibr">18</xref>,<xref rid="pbio.3000966.ref039" ref-type="bibr">39</xref>], we assumed that psychiatric disorder factors were not associated with whole brain connectivity, but rather with a specific subset of connections. Therefore, we used logistic regression with LASSO, a sparse machine learning algorithm, to select the optimal subset of FCs [<xref rid="pbio.3000966.ref040" ref-type="bibr">40</xref>]. We have already succeeded in constructing generalizable brain network markers of ASD, melancholic MDD, SCZ, and obsessive compulsive disorder [<xref rid="pbio.3000966.ref016" ref-type="bibr">16</xref>–<xref rid="pbio.3000966.ref018" ref-type="bibr">18</xref>,<xref rid="pbio.3000966.ref039" ref-type="bibr">39</xref>] by using a similar sparse estimation method that automatically selects the most important connections. We also tried a support vector machine (SVM) for classification instead of LASSO. However, the performance was not improved compared with that with LASSO (<xref ref-type="supplementary-material" rid="pbio.3000966.s002">S1 Text</xref>).</p>
        <p>To estimate the weights of logistic regression and a hyperparameter that determines how many FCs were used, we conducted a nested cross-validation procedure (<xref ref-type="fig" rid="pbio.3000966.g002">Fig 2</xref>) (see Constructing the MDD classifier using the discovery dataset in the Materials and methods section). We first divided the whole discovery dataset into the training set (9 folds out of 10 folds), which was used for training a model, and the test set (1 fold out of 10 folds), which was used for testing the model. To avoid bias due to the difference in the number of patients with MDD and HCs, we used an undersampling method for equalizing the numbers between the MDD and HC groups [<xref rid="pbio.3000966.ref041" ref-type="bibr">41</xref>]. Since only a subset of training data is used after undersampling, we repeated the random sampling procedure 10 times (i.e., subsampling). When we performed undersampling and subsampling procedures, we matched the mean age between MDD and HC groups in each subsample. We then fitted a model to each subsample while tuning a regularization parameter in an inner loop of nested cross validation, resulting in 10 classifiers. The mean classifier-output value (diagnostic probability) was considered indicative of the classifier output. Diagnostic probability values of &gt;0.5 were considered to be indicative of an MDD diagnosis. We calculated the area under the curve (AUC), accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Furthermore, we evaluated the classifier performance for the unbalanced dataset using the Matthews correlation coefficient (MCC) [<xref rid="pbio.3000966.ref042" ref-type="bibr">42</xref>,<xref rid="pbio.3000966.ref043" ref-type="bibr">43</xref>], which takes into account the ratio of the confusion matrix size.</p>
        <fig id="pbio.3000966.g002" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pbio.3000966.g002</object-id>
          <label>Fig 2</label>
          <caption>
            <title>Schematic representation of the procedure for training the MDD classifier and evaluation of predictive power.</title>
            <p>The MDD classifier was constructed using a nested cross-validation procedure in the discovery dataset. We also used undersampling and subsampling techniques. Generalization performances were evaluated by applying the constructed classifiers to the independent validation dataset. The machine learning classifiers are represented by PC cartoons. CV, cross-validation; HC, healthy control; MDD, major depressive disorder.</p>
          </caption>
          <graphic xlink:href="pbio.3000966.g002"/>
        </fig>
        <p>The classifier distinguished MDD and HC populations with an accuracy of 66% in the discovery dataset. The corresponding AUC was 0.74, indicating acceptable discriminatory ability. <xref ref-type="fig" rid="pbio.3000966.g003">Fig 3A</xref> shows that the 2 diagnostic probability distributions of the MDD and HC populations were clearly separated by the 0.5 threshold (right, MDD; left, HC) for the discovery dataset. The sensitivity, specificity, PPV, and NPV were 72%, 65%, 0.34, and 0.90, respectively. This classifier led to an acceptable MCC of 0.30. We found that acceptable classification accuracy was achieved for the full dataset as well as for the individual datasets from 3 of the imaging sites (<xref ref-type="fig" rid="pbio.3000966.g003">Fig 3B</xref>) to similar degrees. Only HC individuals were identified in the SWA dataset; however, notably, its probability distribution was comparable to the HC populations at other sites.</p>
        <fig id="pbio.3000966.g003" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pbio.3000966.g003</object-id>
          <label>Fig 3</label>
          <caption>
            <title>MDD classifier performances in both datasets.</title>
            <p><bold>(a)</bold> The probability distribution for the diagnosis of MDD in the discovery dataset and <bold>(b)</bold> probability distributions for each imaging site. MDD and HC distributions are depicted in red and blue, respectively. <bold>(c)</bold> The probability distribution for the diagnosis of MDD in the independent validation dataset and <bold>(d)</bold> probability distributions for each imaging site. MDD and HC distributions are depicted in red and blue, respectively. The numerical data used in this figure are included in <xref ref-type="supplementary-material" rid="pbio.3000966.s001">S1 Data</xref>. AUC, area under the curve; COI, Center of Innovation in Hiroshima University; HC, healthy control; HKH, Hiroshima Kajikawa Hospital; HRC, Hiroshima Rehabilitation Center; HUH, Hiroshima University Hospital; KUT, Kyoto University; MCC, Matthews correlation coefficient; MDD, major depressive disorder; NPV, negative predictive value; PPV, positive predictive value; SWA, Showa University; UTO, University of Tokyo; UYA, Yamaguchi University. OTHER, the data from OpenNeuro (<ext-link ext-link-type="uri" xlink:href="https://openneuro.org/datasets/ds002748/versions/1.0.0">https://openneuro.org/datasets/ds002748/versions/1.0.0</ext-link>).</p>
          </caption>
          <graphic xlink:href="pbio.3000966.g003"/>
        </fig>
        <p>We tested the generalizability of the classifier using an independent validation dataset. We created 100 classifiers of MDD (10-fold × 10 subsamples); therefore, we applied all trained classifiers to the independent validation dataset. Next, we averaged the 100 outputs (diagnostic probability) for each participant and considered the participant as a patient with MDD if the averaged diagnostic probability value was &gt;0.5. The classifier distinguished the MDD and HC populations with an accuracy of 66% in the independent validation dataset. If the accuracy for the validation dataset is much smaller than that of the discovery dataset, overfitting is strongly suggested, and the reproducibility of the results is put into doubt. In our case, 66% accuracy for the validation dataset was actually same with 66% accuracy for the discovery dataset, and this concern does not apply. The corresponding AUC was 0.74 (permutation test, <italic>P &lt;</italic> 0.01, 1-sided), indicating an acceptable discriminatory ability. <xref ref-type="fig" rid="pbio.3000966.g003">Fig 3C</xref> shows that the 2 diagnostic probability distributions of the MDD and HC populations were clearly separated by the 0.5 threshold (right, MDD; left, HC). The sensitivity, specificity, PPV, and NPV were 72%, 61%, 0.60, and 0.73, respectively. This approach led to an acceptable MCC of 0.33 (permutation test, <italic>P &lt;</italic> 0.01, 1-sided). In addition, acceptable classification accuracy was achieved for the individual datasets of the 5 imaging sites (<xref ref-type="fig" rid="pbio.3000966.g003">Fig 3D</xref>).</p>
        <p>To investigate whether our classifier can be generalized to milder depression, we applied our classifier to patients with MDD with low BDI scores (score ≤ 20, <italic>n</italic> = 30) in the independent validation dataset. As a result, 21 of the 30 patients were correctly classified as having MDD (accuracy of 70%), a similar performance level to when the classifier was applied to all patients with MDD. In addition, we assessed whether the proportion of antidepressants, anxiolytics, antipsychotics, and mood stabilizers used in the milder group and severe group were statistically different. We found that the milder group used significantly lesser antidepressants than the severe group (antidepressant: milder = 19/30, severe = 124/155, <italic>z</italic> = 2.00, <italic>P</italic> = 0.046; anxiolytic: milder = 10/30, severe = 65/155, <italic>z</italic> = 0.88, <italic>P</italic> &gt; 0.38; antipsychotic: milder = 9/30, severe = 33/155, <italic>z</italic> = 1.04, <italic>P</italic> &gt; 0.3; mood stabilizer: milder = 1/30, severe = 13/155, <italic>z</italic> = 0.96, <italic>P</italic> &gt; 0.34). Since we confirmed that there was no significant difference in the classification performance between the 2 groups, these results suggest that our brain network marker is not derived from the effects of different doses of antidepressants on brain circuits. Moreover, all patients with MDD at the KUT imaging site, which is included in the discovery dataset, were treatment resistant (treatment-resistant depression: adequate use of 2 or more antidepressants for 4 to 6 weeks is not efficacious, or intolerance to 2 or more antidepressants exists). We calculated the classification accuracy only at KUT and obtained the same performance level (accuracy = 71%). These results suggest that the current MDD classifier can be generalized to milder depression, as well as to treatment-resistant patients with MDD.</p>
        <p>Furthermore, we investigated the correlation between the classifier’s output (probability of depression) and depressive symptoms (BDI score). We found significant correlations in both the discovery dataset and validation dataset (discovery dataset: <italic>r</italic> = 0.29, <italic>P</italic> &lt; 1.0×10<sup>−10</sup>, validation dataset: <italic>r</italic> = 0.32, <italic>P</italic> &lt; 1.0×10<sup>−11</sup>). However, we were not able to find consistently significant correlations within each group (HC and MDD groups) in both datasets (discovery dataset: MDD [<italic>r</italic> = −0.07, <italic>P</italic> = 0.46], HC [<italic>r</italic> = 0.13, <italic>P</italic> = 0.010]; validation dataset: MDD [<italic>r</italic> = 0.0043, <italic>P</italic> = 0.95], HC [<italic>r</italic> = −0.13, <italic>P</italic> = 0.04]).</p>
        <p>To rule out the possibility that the classifier’s performance is driven by age, we constructed our brain network marker using the datasets in which the mean age was matched between MDD and HC groups. We further assessed whether we can predict classifier scores (probability of depression) based on age, sex, and the amount of motion (frame-wise displacement [FD]) or the combination of head movement parameters (<italic>x</italic>, <italic>y</italic>, <italic>z</italic>, yaw, pitch, and roll), respectively [<xref rid="pbio.3000966.ref044" ref-type="bibr">44</xref>]. As a result, we confirmed that we could not predict classifier scores based on age, sex, and the amount of motion (FD) or the combination of head movement parameters (<xref ref-type="supplementary-material" rid="pbio.3000966.s003">S2 Text</xref> and <xref ref-type="supplementary-material" rid="pbio.3000966.s008">S1 Fig</xref>). These results indicate that the classifier’s performance was unlikely to have been driven by confounds.</p>
        <p>Regarding the effectiveness of the developed network marker, although discriminability was acceptable (AUC = 0.74) in the independent validation dataset, the performance of the PPV was low in the discovery dataset (0.34). This occurred because the number of patients with MDD was much smaller than that of HCs (about 4 times as many HCs as MDDs) in the discovery dataset. By contrast, in the independent validation dataset, in which the number of HCs was about 1.5 times as high as the number of MDDs, the PPV, at 0.60, was acceptable. When applying a developed network marker in clinical practice, we assume this marker to be applied to those who actually visit the hospital. Therefore, the actual PPV will be acceptable in clinical practice because the prevalence of MDD may be relatively higher compared with the prevalence of MDD in the general population. Furthermore, in the independent validation dataset, when we divided the dataset into low- and high-risk groups based on the cutoff value (probability of MDD being 0.52) determined in the discovery dataset [<xref rid="pbio.3000966.ref045" ref-type="bibr">45</xref>], the odds (sensitivity/1 − sensitivity) were 1.92 in the high-risk group. Moreover, the odds ratio was 4.95 when the odds in the low group were set to 1. That is, the output of the classifier (probability of MDD) will be useful information for psychiatrists as a physical measure supplementing patients’ symptoms and signs in order to make a diagnosis. We checked the stability of our developed network marker to assess whether the same subject was consistently classified into the same class when the subject was scanned multiple times at various imaging sites. We applied our marker to a traveling subject dataset in which 9 healthy participants (all male participants; age range, 24 to 32 years; mean age, 27 ± 2.6 years) were scanned about 50 times at 12 different sites, producing a total of 411 scans (<xref ref-type="supplementary-material" rid="pbio.3000966.s015">S3 Table</xref>). We achieved a high accuracy in this dataset (mean accuracy = 84.5, 1SD = 12.8, across participants). This result indicates that our developed network marker has high stability even if the same subject is scanned multiple times at various imaging sites.</p>
        <p>To objectively compare and verify the stability of diagnosis by our brain network marker with that of the diagnosis by clinicians based on the DSM, we performed a new simulation. In this simulation, we prepared a surrogate set of 1,000 participants who have a “true” probability of depression (0 &lt; <italic>p</italic>(<italic>MDD</italic>) &lt; 1). In reality, we used the classifier’s outputs for real patients from our datasets as the true probability. We assumed that the rater’s noise (<italic>N</italic>(0, Σ)) was added to the probability of depression (<inline-formula id="pbio.3000966.e001"><alternatives><graphic xlink:href="pbio.3000966.e001.jpg" id="pbio.3000966.e001g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M1"><mml:mover accent="true"><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>(</mml:mo><mml:mi>M</mml:mi><mml:mi>D</mml:mi><mml:mi>D</mml:mi><mml:mo>)</mml:mo></mml:math></alternatives></inline-formula>), and a participant with <inline-formula id="pbio.3000966.e002"><alternatives><graphic xlink:href="pbio.3000966.e002.jpg" id="pbio.3000966.e002g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M2"><mml:mover accent="true"><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>(</mml:mo><mml:mi>M</mml:mi><mml:mi>D</mml:mi><mml:mi>D</mml:mi><mml:mo>)</mml:mo></mml:math></alternatives></inline-formula> = 0.5 or more was diagnosed with MDD. By assuming 2 raters, we can calculate a diagnostic agreement rate between these 2 raters’ diagnoses (kappa). Based on this simulation, we estimated the rater’s variance Σ = 0.0149 when kappa is 0.28 [<xref rid="pbio.3000966.ref028" ref-type="bibr">28</xref>,<xref rid="pbio.3000966.ref029" ref-type="bibr">29</xref>]. Next, we assessed the variance of our classifier’s output across imaging sites. We applied our classifier to a traveling subject dataset. We evaluated the inter-rater variance of our classifier’s output assuming that each MRI scanner was a rater. We estimated whole-variance (variance across all about 50 scans), between-sites-variance (we calculated the average of 2 or 3 scans per imaging site and then took the variance across the average values), and within-site-variance (variance across 15 scans at 1 imaging site) in each participant. As a result, the whole-variance was 0.0061, the between-sites-variance was 0.0037, and the within-site-variance was 0.0055 averaged across participants. These values were about 25%~40% of the variance between clinicians in the above simulation. These results indicate that the diagnosis by our brain network marker could be more objective and stable than the diagnosis by clinicians, even considering the variance across fMRI scanners and imaging sites.</p>
        <p>To assess the effects of harmonization, we compared prediction performances and the number of selected FCs among brain network markers constructed with harmonization and without harmonization for the discovery dataset and the independent validation dataset, respectively. As a result, we found significant improvements in the prediction performance by harmonization for the independent validation dataset, but not by harmonization for the discovery dataset (<xref ref-type="supplementary-material" rid="pbio.3000966.s004">S3 Text</xref>, <xref ref-type="supplementary-material" rid="pbio.3000966.s016">S4 Table</xref>, and <xref ref-type="supplementary-material" rid="pbio.3000966.s009">S2 Fig</xref>). One possible explanation for which the harmonization for the discovery dataset did not improve the classification performance was that the site effect may have been sufficiently small in the discovery dataset since the discovery dataset was acquired using a unified imaging protocol. However, this was not the case in the validation dataset. A detailed analysis on how classification performance with/without harmonization depends on the size and patterns of the site and disease difference would make for an interesting future research topic. On the other hand, the number of selected FCs was the largest for traveling subject harmonization (25 FCs), compared with 23 and 21 without harmonization and ComBat, respectively (we explained how to select important FCs for MDD diagnosis in important FCs for MDD diagnosis in the Results section) (<xref ref-type="supplementary-material" rid="pbio.3000966.s004">S3 Text</xref>, <xref ref-type="supplementary-material" rid="pbio.3000966.s016">S4 Table</xref>, and <xref ref-type="supplementary-material" rid="pbio.3000966.s009">S2 Fig</xref>). This suggests that we could extract more brain circuit information with regard to MDD from the data by the traveling subject harmonization.</p>
        <p>We investigated whether the discrimination performances were different across imaging sites in the independent validation dataset. We calculated the 95% confidence intervals (CIs) of the discrimination performances (AUC, accuracy, sensitivity, and specificity) using a bootstrap method for every imaging site. We repeated the bootstrap procedure 1,000 times and calculated the 95% CI for each site. We then checked whether there was a site whose CI did not overlap with the CIs of other imaging sites. We were unable to find such an imaging site, suggesting no significant systematic difference (<xref ref-type="supplementary-material" rid="pbio.3000966.s005">S4 Text</xref> and <xref ref-type="supplementary-material" rid="pbio.3000966.s010">S3 Fig</xref>). We further assessed the prediction performance when we used a parcellation scheme other than Glasser’s region of interest (ROI). We found that there was no large difference in the prediction performance dependent on ROI numbers or parcellation schemes (<xref ref-type="supplementary-material" rid="pbio.3000966.s006">S5 Text</xref> and <xref ref-type="supplementary-material" rid="pbio.3000966.s011">S4 Fig</xref>).</p>
      </sec>
      <sec id="sec007">
        <title>Important FCs for MDD diagnosis</title>
        <p>We examined important resting-state FCs for an MDD diagnosis. Briefly, we counted the number of times an FC was selected by LASSO during the 10-fold cross-validation (CV). We considered this FC to be important if this number was significantly higher than the threshold for randomness, according to a permutation test. We permuted the diagnostic labels of the discovery dataset and conducted a 10-fold CV and 10-subsampling procedure, and we repeated this permutation procedure 100 times. We then used the number of counts for each connection selected by the sparse algorithm during 10 subsamplings × 10-fold CV (max 100 times) as a statistic in every permutation dataset. To control for the multiple comparison problem, we set a null distribution as the max distribution of the number of counts over all FCs and set our statistical significance to a certain threshold (permutation test, <italic>P</italic> &lt; 0.05, 1-sided).</p>
        <p><xref ref-type="fig" rid="pbio.3000966.g004">Fig 4A</xref> shows the spatial distribution of the 25 FCs that were automatically and unbiasedly identified from the data for the reliable classification of MDD and HC by the machine learning algorithms. We hereafter summarize the characteristics of these FCs. (1) The FC between the left and right insula had the largest difference between patients with MDD and HCs (FC#12 in <xref ref-type="fig" rid="pbio.3000966.g004">Fig 4B</xref>). (2) A total of 19 of 25 FCs exhibited “under-connectivity,” and only 6 FCs exhibited “over-connectivity.” Note that the state of FC exhibiting the smaller (i.e., more negative) and greater (more positive) mean correlation values in the MDD population than the HC population is termed under- and over-connectivity, respectively. (3) Two FCs (FC#11 and FC#23 in <xref ref-type="fig" rid="pbio.3000966.g004">Fig 4B</xref>) were related to the subgenual anterior cingulate cortex (sgACC). (4) FC#2 was FC between the sensory motor cortex (postcentral cortex) and the left dorsolateral prefrontal cortex (left DLPFC). A detailed list of the FCs is provided in <xref ref-type="supplementary-material" rid="pbio.3000966.s017">S5 Table</xref>. Furthermore, the mean FC values for HCs and patients with MDD in the discovery dataset (<xref ref-type="fig" rid="pbio.3000966.g005">Fig 5A</xref>) were similar to those in the independent validation dataset (<xref ref-type="fig" rid="pbio.3000966.g005">Fig 5B</xref>), pointing to the reproducibility of the FC values.</p>
        <fig id="pbio.3000966.g004" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pbio.3000966.g004</object-id>
          <label>Fig 4</label>
          <caption>
            <title>Important FCs for MDD diagnosis.</title>
            <p><bold>(a)</bold> The 25 FCs viewed from left, back, right, and top. Interhemispheric connections are shown in the back and top views only. Regions are color-coded according to the intrinsic network. The state of functional connectivity exhibiting the smaller (i.e., more negative) and greater (more positive) mean correlation index in the MDD population than in the HC population is termed under- (blue line) and over-connectivity (red line), respectively. The width of the line represents the effect size of the difference (<italic>t</italic>-value) in the FC values between MDD and HC groups. <bold>(b)</bold> Listed here are the laterality and anatomical identification of the ROI as identified by the AAL and associated intrinsic networks related to the 25 FCs. AAL, anatomical automatic labeling; DMN, default mode network; FC, functional connectivity; FPN, fronto-parietal network; HC, healthy control; MDD, major depressive disorder; ROI, region of interest. An interactive display of each connection in <xref ref-type="fig" rid="pbio.3000966.g004">Fig 4A</xref> can be accessed from <ext-link ext-link-type="uri" xlink:href="https://bicr.atr.jp/~imamizu/p5/MDD/">https://bicr.atr.jp/~imamizu/p5/MDD/</ext-link>.</p>
          </caption>
          <graphic xlink:href="pbio.3000966.g004"/>
        </fig>
        <fig id="pbio.3000966.g005" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pbio.3000966.g005</object-id>
          <label>Fig 5</label>
          <caption>
            <title>Reproducibility of important FCs for MDD diagnosis.</title>
            <p><bold>(a)</bold> The FC values for both HCs (blue bar) and patients with MDD (red bar) in the discovery dataset. <bold>(b)</bold> The FC values for both HCs and patients with MDD in the independent validation dataset. The error bar represents the standard error. The numerical data used in this figure are included in <xref ref-type="supplementary-material" rid="pbio.3000966.s001">S1 Data</xref>. FC, functional connectivity; HCs, healthy controls; MDD, major depressive disorder.</p>
          </caption>
          <graphic xlink:href="pbio.3000966.g005"/>
        </fig>
      </sec>
      <sec id="sec008">
        <title>Generalization of the MDD classifier to other disorders</title>
        <p>We sought to investigate and confirm the spectral structure among the disorders as revealed by previous studies [<xref rid="pbio.3000966.ref016" ref-type="bibr">16</xref>–<xref rid="pbio.3000966.ref018" ref-type="bibr">18</xref>]. If the MDD classifier predicts patients with a different disorder from patients from MDD, then the probability of diagnosis for patients with that disorder should be over 0.5. In this case, we may say that the patients possess some degree of MDD-ness and that this disorder is related to MDD according to the imaging biological dimension. To assess this possibility, we applied our MDD classifier to patients with SCZ and ASD included in the DecNef Project Brain Data Repository (<xref ref-type="supplementary-material" rid="pbio.3000966.s018">S6 Table</xref>, <ext-link ext-link-type="uri" xlink:href="https://bicr-resource.atr.jp/srpbsopen/">https://bicr-resource.atr.jp/srpbsopen/</ext-link>).</p>
        <p>We found that patients with SCZ have high MDD-ness (accuracy = 76%, <italic>P</italic> = 2.0×10<sup>−12</sup>, 2-way binomial test) and that patients with ASD did not have high MDD-ness (accuracy = 55%, <italic>P</italic> = 0.20, 2-way binomial test) (<xref ref-type="supplementary-material" rid="pbio.3000966.s007">S6 Text</xref> and <xref ref-type="supplementary-material" rid="pbio.3000966.s012">S5 Fig</xref>). This result suggests that the MDD classifier generalizes to SCZ but not to ASD. We note that our discovery dataset for the construction of the MDD classifier did not include any patients with MDD who were comorbid with SCZ and only 1 patient with MDD who was comorbid with ASD. Therefore, our classifier was not affected by either SCZ or ASD diagnosis. Thus, the above generalization of the MDD classifier may point to a certain neurobiological relevance among diseases.</p>
      </sec>
    </sec>
    <sec sec-type="conclusions" id="sec009">
      <title>Discussion</title>
      <p>In this study, we thoroughly considered conditions and resolved difficulties in order to ensure the generalization of our brain network marker in the independent validation dataset, which does not include any imaging sites of the discovery dataset. We succeeded in generalizing our network marker to the big independent validation dataset. This generalization ensures scientific reproducibility and the clinical applicability of rs-fMRI. Without this fundamental evidence, we cannot proceed to the development of rs-fMRI-based subtyping, evaluation of drug effects, or exploration of a multi-spectrum disorder in the biological dimensions, as mentioned in the Introduction section. Therefore, our study found generalizable psychiatric biomarkers, which the fields of psychiatry, neuroscience, and computational theory have long sought out, to no avail, since the RDoC initiative.</p>
      <p>We developed generalizable brain network markers without restriction to treatment-resistant or melancholic MDD. Most previous studies have reported the performance of a prediction model using data from the same imaging sites using a CV technique. However, because of large imaging site differences in rs-fMRI data [<xref rid="pbio.3000966.ref026" ref-type="bibr">26</xref>,<xref rid="pbio.3000966.ref046" ref-type="bibr">46</xref>], CV methods generally induce inflations in performance. To ensure reproducibility, it is critical to demonstrate the generalizability of the models with an independent validation dataset acquired from completely different imaging sites [<xref rid="pbio.3000966.ref015" ref-type="bibr">15</xref>,<xref rid="pbio.3000966.ref020" ref-type="bibr">20</xref>–<xref rid="pbio.3000966.ref022" ref-type="bibr">22</xref>]. To overcome the abovementioned site differences, we reduced site differences in a multisite large-scale rs-fMRI dataset using our novel harmonization method. Next, we constructed an MDD classifier that was acceptably generalized to the independent validation dataset. Acceptable generalized prediction performance was also achieved for the 5 individual imaging site datasets (<xref ref-type="fig" rid="pbio.3000966.g003">Fig 3D</xref>). This generalization was achieved even though the imaging protocols in the independent validation datasets were different from the discovery dataset. There are only 2 studies in which generalization of FC-based MDD classifiers to independent validation data was demonstrated [<xref rid="pbio.3000966.ref012" ref-type="bibr">12</xref>,<xref rid="pbio.3000966.ref016" ref-type="bibr">16</xref>]. To the best of our knowledge, our work is the first to construct a generalized classifier of MDD without restriction to certain MDD subtypes: Drysdale concentrated on patients with MDD who were treatment resistant, and Ichikawa restricted patients with the melancholic subtype of MDD. Constructing the whole MDD marker is important for subsequent MDD subtyping analyses. This was achieved for the first time by collecting data on a large variety of patients with MDD from multiple imaging sites and objectively harmonizing them with a traveling subject dataset. Furthermore, our simulation result indicates that our brain network marker of MDD could more objectively and stably diagnose MDD than the diagnosis by clinicians based on the DSM, even in consideration of the variance across fMRI scanners and imaging sites.</p>
      <p>For the application of our harmonization method to the actual medical field, the best classification performance will be achieved when (1) all imaging sites are involved in a traveling subject dataset; (2) the traveling subject harmonization is applied throughout the discovery and the validation datasets; and (3) a brain network marker is reconstructed from the harmonized datasets. However, when we use our method under a medical device program approval, it seems more realistic to conduct the harmonization without using the discovery dataset because imaging sites cannot be added to the dataset after the approval. As such, the method in this paper or the method of applying the traveling subject harmonization within the independent validation dataset should be preferred. It is important to note that because of the absence of the traveling subject dataset, traveling subject harmonization was not possible for the independent validation dataset, and we were forced to use ComBat in this case.</p>
      <p>The machine learning algorithms reliably identified the 25 FCs that are important for MDD diagnosis (<xref ref-type="fig" rid="pbio.3000966.g004">Fig 4</xref> and <xref ref-type="supplementary-material" rid="pbio.3000966.s017">S5 Table</xref>). We hereafter summarize the characteristics of these FCs. (1) The FC between the left and right insula revealed the largest differences between patients with MDD and HCs (FC#12 in <xref ref-type="fig" rid="pbio.3000966.g004">Fig 4B</xref>). Abnormalities in the insula were not only found in patients with MDD [<xref rid="pbio.3000966.ref047" ref-type="bibr">47</xref>,<xref rid="pbio.3000966.ref048" ref-type="bibr">48</xref>] but also reported as common abnormalities (reduced gray matter volume) among psychiatric disorders [<xref rid="pbio.3000966.ref004" ref-type="bibr">4</xref>]. Therefore, the connectivity associated with the insula is a potential candidate for the neurobiological dimension to understand a multi-spectrum disorder. (2) A total of 19 of 25 FCs exhibited “under-connectivity,” and only 6 FCs exhibited “over-connectivity.” Note that the state of FC exhibiting the smaller (i.e., more negative) and greater (more positive) mean correlation values in the MDD population than the HC population is termed under- and over-connectivity, respectively. (3) Two FCs (FC#11 and FC#23 in <xref ref-type="fig" rid="pbio.3000966.g004">Fig 4B</xref>) were related to the sgACC. According to a previous study, sgACC is metabolically overactive in treatment-resistant depression and is known as an important treatment target of deep brain stimulation for MDD [<xref rid="pbio.3000966.ref049" ref-type="bibr">49</xref>]. (4) FC#2 was the FC between the sensory motor cortex (postcentral cortex) and the left DLPFC. Previous study shows that the left DLPFC is anticorrelated with the sgACC and is known as an important treatment target of repetitive transcranial magnetic stimulation (rTMS) for MDD [<xref rid="pbio.3000966.ref050" ref-type="bibr">50</xref>]. These results indicate that we need further analyses to clarify how the classifier’s output and abnormalities in each FC are associated with cognitive and affective functions in a future study.</p>
      <p>Ultimately, it would be very important to understand the relationships across disorders (multi-disorder spectrum). We found that SCZ had a high tendency (similarity) toward MDD, while ASD had no such a tendency toward MDD (<xref ref-type="supplementary-material" rid="pbio.3000966.s012">S5 Fig</xref>). This result suggests that the MDD classifier generalizes to SCZ but not to ASD. Thus, the above generalization of the MDD classifier may point to a certain neurobiological relevance among diseases. Our patients with SCZ were in the chronic phase and had negative symptoms. Considering that the negative symptoms of SCZ are similar to those of depression [<xref rid="pbio.3000966.ref051" ref-type="bibr">51</xref>–<xref rid="pbio.3000966.ref056" ref-type="bibr">56</xref>], the generalization hypothesizes the existence of neurobiological dimensions underlying the common symptoms between SCZ and MDD. We need further analyses to quantitatively examine the neurobiological relationship between SCZ and MDD by gathering more precise information on SCZ (symptoms and medication history). To further understand the multi-disorder spectrum, we developed markers of SCZ and ASD using the same method as in this study in addition to a brain network marker of MDD (<xref ref-type="supplementary-material" rid="pbio.3000966.s007">S6 Text</xref>). As a result, we found an interesting asymmetric relationship among these disorders: The classifier of SCZ did not generalize to patients with MDD (<xref ref-type="supplementary-material" rid="pbio.3000966.s012">S5 Fig</xref>). This kind of asymmetry in the classifiers had also been found between the SCZ classifier and the ASD classifier (the ASD classifier generalized to SCZ, but the SCZ classifier did not generalize to ASD) [<xref rid="pbio.3000966.ref017" ref-type="bibr">17</xref>,<xref rid="pbio.3000966.ref018" ref-type="bibr">18</xref>]. These results provide us with important information for understanding the biological relationships between diseases. For example, the above asymmetry between the SCZ and ASD or MDD classifiers suggests that the brain network related to SCZ is characterized by a larger diversity than that of ASD or MDD and that it partially shares information with the smaller brain network related to ASD or MDD than that of SCZ [<xref rid="pbio.3000966.ref018" ref-type="bibr">18</xref>].</p>
      <p>Although biomarkers have been developed with the aim of diagnosing patients, the focus has shifted to the identification of biomarkers that can determine therapeutic targets, such as theranostic biomarkers [<xref rid="pbio.3000966.ref057" ref-type="bibr">57</xref>,<xref rid="pbio.3000966.ref058" ref-type="bibr">58</xref>], which would allow for more personalized treatment approaches. The 25 FCs discovered in this study are promising candidates as theranostic biomarkers for MDD because they are related to the MDD diagnosis. Future work should investigate whether modulation of FC could be an effective treatment in MDD by using an intervention method with regard to FC, such as functional connectivity neurofeedback training [<xref rid="pbio.3000966.ref057" ref-type="bibr">57</xref>–<xref rid="pbio.3000966.ref061" ref-type="bibr">61</xref>].</p>
    </sec>
    <sec sec-type="materials|methods" id="sec010">
      <title>Materials and methods</title>
      <sec id="sec011">
        <title>Ethics statement</title>
        <p>All participants in all datasets provided written informed consent. All recruitment procedures and experimental protocols were approved by the institutional review boards of the principal investigators’ respective institutions (Advanced Telecommunications Research Institute International [approval numbers: 13–133, 14–133, 15–133, 16–133, 17–133, and 18–133], Hiroshima University [E-38], Kyoto Prefectural University of Medicine [RBMR-C-1098], Showa University [SWA] [B-2014-019 and UMIN000016134], the University of Tokyo [UTO] Faculty of Medicine [3150], Kyoto University [C809 and R0027], and Yamaguchi University [H23-153 and H25-85]) and conducted in accordance with the Declaration of Helsinki.</p>
      </sec>
      <sec id="sec012">
        <title>Participants</title>
        <p>We used 2 rs-fMRI datasets for the analyses: (1) The “discovery dataset” contained data from 713 participants (564 HCs from 4 sites, 149 patients with MDD from 3 sites; <xref rid="pbio.3000966.t001" ref-type="table">Table 1</xref>). Each participant underwent a single rs-fMRI session, which lasted for 10 min. Within the Japanese SRPBS DecNef project, we planned to acquire the rs-fMRI data using a unified imaging protocol (<xref ref-type="supplementary-material" rid="pbio.3000966.s013">S1 Table</xref>; <ext-link ext-link-type="uri" xlink:href="http://bicr.atr.jp/rs-fmri-protocol-2/">http://bicr.atr.jp/rs-fmri-protocol-2/</ext-link>). However, there were 2 erroneous phase-encoding directions (P→A and A→P). In addition, different sites had different MRI hardware (<xref ref-type="supplementary-material" rid="pbio.3000966.s013">S1 Table</xref>). During the rs-fMRI scans, participants were instructed to “Relax. Stay Awake. Fixate on the central crosshair mark, and do not concentrate on specific things.” This dataset was acquired in the SRPBS DecNef project from 2014. (2) The “independent validation dataset” contained data from 449 participants (264 HCs and 185 patients with MDD from 4 independent sites; <xref rid="pbio.3000966.t001" ref-type="table">Table 1</xref>). Data were acquired following protocols reported in <xref ref-type="supplementary-material" rid="pbio.3000966.s013">S1 Table</xref>. The sites used were different from the discovery dataset. Each participant underwent a single rs-fMRI session lasting for 5 or 8 min. This data set was acquired in other projects from 2008 and not the SRPBS DecNef. The dataset collected from Hiroshima University Hospital (HUH), Hiroshima Kajikawa Hospital (HKH), and Hiroshima Rehabilitation Center (HRC) in the independent validation dataset were acquired by “development of diagnosis and treatment techniques for patients with severe intractable depression and insensitivity to antidepressant treatment based on molecular and cellular researches on BDNF and depression” of the Japan Science and Technology Agency Core Research for Evolutional Science and Technology (CREST) from 2008 and by “understanding the neurocircuit–molecular mechanism underlying pathophysiology of depression and the development of its neuroscience-based diagnosis and treatment” of the SRPBS from 2011. The dataset collected from Yamaguchi University (UYA) was acquired by “exploration of the biological markers for discrimination of heterogeneous pathophysiology of major depressive disorder” of the SRPBS from 2012. We further included the dataset collected from a country outside Japan (OpenNeuro: <ext-link ext-link-type="uri" xlink:href="https://openneuro.org/datasets/ds002748/versions/1.0.0">https://openneuro.org/datasets/ds002748/versions/1.0.0</ext-link>) in the final independent validation dataset (21 HCs and 51 patients with MDD; <xref rid="pbio.3000966.t001" ref-type="table">Table 1</xref>). In both datasets, depression symptoms were evaluated using the BDI-II score obtained from most participants in each dataset. This study was carried out in accordance with the recommendations of the institutional review boards of the principal investigators’ respective institutions (Hiroshima University, Kyoto University, Showa University, University of Tokyo, and Yamaguchi University) with written informed consent from all subjects in accordance with the Declaration of Helsinki. The protocol was approved by the institutional review boards of the principal investigators’ respective institutions (Hiroshima University, Kyoto University, Showa University, University of Tokyo, and Yamaguchi University). Most data utilized in this study can be downloaded publicly from the DecNef Project Brain Data Repository at <ext-link ext-link-type="uri" xlink:href="https://bicr-resource.atr.jp/srpbsopen/">https://bicr-resource.atr.jp/srpbsopen/</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://bicr.atr.jp/dcn/en/download/harmonization/">https://bicr.atr.jp/dcn/en/download/harmonization/</ext-link>, and <ext-link ext-link-type="uri" xlink:href="https://openneuro.org/datasets/ds002748/versions/1.0.0">https://openneuro.org/datasets/ds002748/versions/1.0.0</ext-link>. The data availability statements of each site are described in <xref ref-type="supplementary-material" rid="pbio.3000966.s013">S1 Table</xref>.</p>
      </sec>
      <sec id="sec013">
        <title>Preprocessing and calculation of the resting-state FC matrix</title>
        <p>We preprocessed the rs-fMRI data using FMRIPREP version 1.0.8 [<xref rid="pbio.3000966.ref062" ref-type="bibr">62</xref>]. The first 10 s of the data were discarded to allow for T1 equilibration. Preprocessing steps included slice-timing correction, realignment, coregistration, distortion correction using a field map, segmentation of T1-weighted structural images, normalization to Montreal Neurological Institute (MNI) space, and spatial smoothing with an isotropic Gaussian kernel of 6 mm full width at half maximum. “Fieldmap-less” distortion correction was performed for the independent validation dataset due to the lack of field map data. For more details on the pipeline, see <ext-link ext-link-type="uri" xlink:href="http://fmriprep.readthedocs.io/en/latest/workflows.html">http://fmriprep.readthedocs.io/en/latest/workflows.html</ext-link>. For 6 participants’ data in the independent validation dataset, the coregistration was unsuccessful, and we therefore excluded these data from further analysis.</p>
      </sec>
      <sec id="sec014">
        <title>Parcellation of brain regions</title>
        <p>To analyze the data using Human Connectome Project (HCP) style surface-based methods, we used ciftify toolbox version 2.0.2 [<xref rid="pbio.3000966.ref063" ref-type="bibr">63</xref>]. This allowed us to analyze our data, which lacked the T2-weighted image required for HCP pipelines, using an HCP-like surface-based pipeline. Next, we used Glasser’s 379 surface-based parcellations (cortical 360 parcellations + subcortical 19 parcellations) as ROIs, considered reliable brain parcellations [<xref rid="pbio.3000966.ref034" ref-type="bibr">34</xref>]. The BOLD signal time courses were extracted from these 379 ROIs. To facilitate the comparison of our results with previous studies, we identified the anatomical names of important ROIs and the names of intrinsic brain networks that included the ROIs using anatomical automatic labeling (AAL) [<xref rid="pbio.3000966.ref064" ref-type="bibr">64</xref>] and Neurosynth (<ext-link ext-link-type="uri" xlink:href="http://neurosynth.org/locations/">http://neurosynth.org/locations/</ext-link>).</p>
      </sec>
      <sec id="sec015">
        <title>Physiological noise regression</title>
        <p>Physiological noise regressors were extracted by applying CompCor [<xref rid="pbio.3000966.ref065" ref-type="bibr">65</xref>]. Principal components were estimated for the anatomical CompCor (aCompCor). A mask to exclude signals with a cortical origin was obtained by eroding the brain mask and ensuring that it contained subcortical structures only. Five aCompCor components were calculated within the intersection of the subcortical mask and the union of the cerebrospinal fluid (CSF) and white matter (WM) masks calculated in the T1-weighted image space after their projection to the native space of functional images in each session. To remove several sources of spurious variance, we used a linear regression with 12 regression parameters, such as 6 motion parameters, average signals over the whole brain, and 5 aCompCor components.</p>
      </sec>
      <sec id="sec016">
        <title>Temporal filtering</title>
        <p>A temporal bandpass filter was applied to the time series using a first-order Butterworth filter with a pass band between 0.01 Hz and 0.08 Hz to restrict the analysis to low-frequency fluctuations, which are characteristic of rs-fMRI BOLD activity [<xref rid="pbio.3000966.ref066" ref-type="bibr">66</xref>].</p>
      </sec>
      <sec id="sec017">
        <title>Head motion</title>
        <p>FD [<xref rid="pbio.3000966.ref067" ref-type="bibr">67</xref>] was calculated for each functional session using Nipype (<ext-link ext-link-type="uri" xlink:href="https://nipype.readthedocs.io/en/latest/">https://nipype.readthedocs.io/en/latest/</ext-link>). FD was used in the subsequent scrubbing procedure. To reduce spurious changes in FC from head motion, we removed volumes with FD &gt;0.5 mm, as proposed in a previous study [<xref rid="pbio.3000966.ref067" ref-type="bibr">67</xref>]. The FD represents head motion between 2 consecutive volumes as a scalar quantity (i.e., the summation of absolute displacements in translation and rotation). Using the aforementioned threshold, 6.3% ± 13.5 volumes (mean ± SD) were removed per rs-fMRI session in all datasets. If the ratio of the excluded volumes after scrubbing exceeded the mean + 3 SD, participants were excluded from the analysis. As a result, 32 participants were removed from all datasets. Thus, we included 683 participants (545 HCs, 138 patients with MDD) in the discovery dataset and 440 participants (259 HCs, 181 patients with MDD) in the independent validation dataset for further analysis.</p>
      </sec>
      <sec id="sec018">
        <title>Calculation of FC matrix</title>
        <p>FC was calculated as the temporal correlation of rs-fMRI BOLD signals across 379 ROIs for each participant. There are a number of different candidates to measure FC, such as the tangent method and partial correlation; however, we used a Pearson’s correlation coefficient because they are the most commonly used values in previous studies. Fisher’s z-transformed Pearson’s correlation coefficients were calculated between the preprocessed BOLD signal time courses of each possible pair of ROIs and used to construct 379 × 379 symmetrical connectivity matrices in which each element represents a connection strength between 2 ROIs. We used 71,631 FC values [(379 × 378)/2] of the lower triangular matrix of the connectivity matrix for further analysis.</p>
      </sec>
      <sec id="sec019">
        <title>Control of site differences</title>
        <p>Next, we used a traveling subject harmonization method to control for site differences in FC in the discovery dataset. This method enabled us to subtract pure site differences (measurement bias), which are estimated from the traveling subject dataset wherein multiple participants travel to multiple sites to assess measurement bias. The participant factor (<bold><italic>p</italic></bold>), measurement bias (<bold><italic>m</italic></bold>), sampling biases (<bold><italic>s</italic></bold><sub>hc</sub>, <bold><italic>s</italic></bold><sub>mdd</sub>), and psychiatric disorder factor (<bold><italic>d</italic></bold>) were estimated by fitting the regression model to the FC values of all participants from the discovery dataset and the traveling subject dataset. For each connectivity, the regression model can be written as follows:
<disp-formula id="pbio.3000966.e003"><alternatives><graphic xlink:href="pbio.3000966.e003.jpg" id="pbio.3000966.e003g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M3"><mml:mi>C</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>y</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="bold">x</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">m</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow></mml:msup><mml:mi mathvariant="bold-italic">m</mml:mi><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="bold">x</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">s</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">h</mml:mi><mml:mi mathvariant="bold-italic">c</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow></mml:msup><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">s</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">h</mml:mi><mml:mi mathvariant="bold-italic">c</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="bold">x</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">s</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">m</mml:mi><mml:mi mathvariant="bold-italic">d</mml:mi><mml:mi mathvariant="bold-italic">d</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow></mml:msup><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">s</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">m</mml:mi><mml:mi mathvariant="bold-italic">d</mml:mi><mml:mi mathvariant="bold-italic">d</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="bold">x</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">d</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow></mml:msup><mml:mi mathvariant="bold-italic">d</mml:mi><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="bold">x</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">p</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow></mml:msup><mml:mi mathvariant="bold-italic">p</mml:mi><mml:mo>+</mml:mo><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mi>e</mml:mi><mml:mo>,</mml:mo></mml:math></alternatives></disp-formula>
<disp-formula id="pbio.3000966.e004"><alternatives><graphic xlink:href="pbio.3000966.e004.jpg" id="pbio.3000966.e004g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M4"><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">h</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">h</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mrow><mml:msubsup><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mn>9</mml:mn></mml:mrow></mml:msubsup><mml:mrow><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>4</mml:mn></mml:mrow></mml:msubsup><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>4</mml:mn></mml:mrow></mml:msubsup><mml:mrow><mml:msub><mml:mrow><mml:msub><mml:mrow><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>h</mml:mi><mml:mi>c</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msubsup><mml:mrow><mml:msub><mml:mrow><mml:msub><mml:mrow><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>d</mml:mi><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="normal">H</mml:mi><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo></mml:math></alternatives></disp-formula>
in which <bold><italic>m</italic></bold> represents the measurement bias (4 sites × 1), <bold><italic>s</italic></bold><sub><bold><italic>hc</italic></bold></sub> represents the sampling bias of HCs (4 sites × 1), <bold><italic>s</italic></bold><sub><bold><italic>mdd</italic></bold></sub> represents the sampling bias of patients with MDD (3 sites × 1), <bold><italic>d</italic></bold> represents the disorder factor (2 × 1), <bold><italic>p</italic></bold> represents the participant factor (9 traveling subjects × 1), <italic>const</italic> represents the average FC value across all participants from all sites, and <inline-formula id="pbio.3000966.e005"><alternatives><graphic xlink:href="pbio.3000966.e005.jpg" id="pbio.3000966.e005g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M5"><mml:mi>e</mml:mi><mml:mo>∼</mml:mo><mml:mi mathvariant="script">N</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msup><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:math></alternatives></inline-formula> represents noise. Measurement biases were removed by subtracting the estimated measurement biases. Thus, the harmonized FC values were set as follows:
<disp-formula id="pbio.3000966.e006"><alternatives><graphic xlink:href="pbio.3000966.e006.jpg" id="pbio.3000966.e006g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M6"><mml:msup><mml:mrow><mml:mi>C</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>H</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>m</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>i</mml:mi><mml:mi>z</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:mi>C</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>y</mml:mi><mml:mo>−</mml:mo><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="bold">x</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">m</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow></mml:msup><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold-italic">m</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>,</mml:mo></mml:math></alternatives></disp-formula>
in which <inline-formula id="pbio.3000966.e007"><alternatives><graphic xlink:href="pbio.3000966.e007.jpg" id="pbio.3000966.e007g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M7"><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="bold-italic">m</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:math></alternatives></inline-formula> represents the estimated measurement bias. More detailed information have been previously described [<xref rid="pbio.3000966.ref026" ref-type="bibr">26</xref>].</p>
        <p>We used the ComBat harmonization method [<xref rid="pbio.3000966.ref035" ref-type="bibr">35</xref>–<xref rid="pbio.3000966.ref038" ref-type="bibr">38</xref>] to control for site differences in FC in the independent validation dataset because we did not have a traveling subject dataset for those sites. We performed harmonization to correct only for the site difference using information on MDD diagnosis, BDI score, age, sex, and dominant hand as auxiliary variables in ComBat. Notably, compared with the conventional regression method, the ComBat method is a more advanced method to control for site effects [<xref rid="pbio.3000966.ref035" ref-type="bibr">35</xref>–<xref rid="pbio.3000966.ref038" ref-type="bibr">38</xref>].</p>
      </sec>
      <sec id="sec020">
        <title>Constructing the MDD classifier using the discovery dataset</title>
        <p>We constructed a brain network marker for MDD that distinguished between HCs and patients with MDD using the discovery dataset based on 71,631 FC values. To construct the network marker, we applied a machine learning technique. Although SVM is often used as a classifier, SVM is not suitable for investigating the contribution of explanatory variables because it is difficult to calculate the contribution of each explanatory variable. Based on our previous study [<xref rid="pbio.3000966.ref017" ref-type="bibr">17</xref>], we assumed that psychiatric disorder factors were not associated with whole brain connectivity, but rather with a specific subset of connections. Therefore, we conducted logistic regression analyses using the LASSO method to select the optimal subset of FCs [<xref rid="pbio.3000966.ref040" ref-type="bibr">40</xref>]. A logistic function was used to define the probability of a participant belonging to the MDD class as follows:
<disp-formula id="pbio.3000966.e008"><alternatives><graphic xlink:href="pbio.3000966.e008.jpg" id="pbio.3000966.e008g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M8"><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>u</mml:mi><mml:mi>b</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>u</mml:mi><mml:mi>b</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>|</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">c</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>u</mml:mi><mml:mi>b</mml:mi></mml:mrow></mml:msub><mml:mo>;</mml:mo><mml:mi mathvariant="bold-italic">w</mml:mi></mml:mrow><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">x</mml:mi><mml:mi mathvariant="normal">p</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:mo>−</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="bold-italic">w</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow></mml:msup><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">c</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>u</mml:mi><mml:mi>b</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:math></alternatives></disp-formula>
in which <bold><italic>y</italic></bold><sub><bold><italic>sub</italic></bold></sub>
<bold><italic>y</italic></bold><sub><bold><italic>sub</italic></bold></sub> represents the class label (MDD, <italic>y</italic> = 1; HC, <italic>y</italic> = 0) of a participant, <bold><italic>c</italic></bold><sub><bold><italic>sub</italic></bold></sub><bold><italic>c</italic></bold><sub><bold><italic>sub</italic></bold></sub> represents an FC vector for a given participant, and <italic>w</italic> represents the weight vector. The weight vector <italic>w</italic> was determined to minimize
<disp-formula id="pbio.3000966.e009"><alternatives><graphic xlink:href="pbio.3000966.e009.jpg" id="pbio.3000966.e009g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M9"><mml:mi>J</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="bold">w</mml:mi></mml:mrow><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>u</mml:mi><mml:mi>b</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mrow><mml:munderover><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>u</mml:mi><mml:mi>b</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:munderover><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">log</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>|</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">c</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">j</mml:mi></mml:mrow></mml:msub><mml:mo>;</mml:mo><mml:mi mathvariant="bold-italic">w</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mrow><mml:mo>+</mml:mo><mml:mi mathvariant="normal">λ</mml:mi><mml:msub><mml:mrow><mml:mo>‖</mml:mo><mml:mrow><mml:mi mathvariant="bold-italic">w</mml:mi></mml:mrow><mml:mo>‖</mml:mo></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:math></alternatives></disp-formula>
in which <inline-formula id="pbio.3000966.e010"><alternatives><graphic xlink:href="pbio.3000966.e010.jpg" id="pbio.3000966.e010g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M10"><mml:msub><mml:mrow><mml:mo>‖</mml:mo><mml:mrow><mml:mi mathvariant="bold-italic">w</mml:mi></mml:mrow><mml:mo>‖</mml:mo></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:msubsup><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>|</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula> and λ represent hyperparameters that control the amount of shrinkage applied to the estimates. To estimate weights of the logistic regression and a hyperparameter λ, we conducted a nested cross-validation procedure (<xref ref-type="fig" rid="pbio.3000966.g002">Fig 2</xref>). In this procedure, we first divided the whole discovery dataset into a training set (9 folds of 10 folds), which used for training a model and a test set (a fold of 10 folds) for testing the model. To minimize bias due to the differences in the numbers of patients with MDD and HCs, we used an undersampling method [<xref rid="pbio.3000966.ref041" ref-type="bibr">41</xref>]. Almost 125 patients with MDD and 125 HCs were randomly sampled from the training set, and the classifier performance was tested using the test set. When we performed the undersampling and subsampling procedures, we matched the mean age between MDD and HC groups in each subsample. Since only a subset of training data is used after undersampling, we repeated the random sampling procedure 10 times (i.e., subsampling). We then fitted a model to each subsample while tuning a regularization parameter in the inner loop of the nested cross-validation, resulting in 10 classifiers. For the inner loop, we used the “<italic>lassoglm</italic>” function in MATLAB (R2016b, Mathworks, USA) and set “NumLambda” to 25 and “CV” to 10. In this inner loop, we first calculated a value of λ just large enough such that the only optimal solution is the all-zeroes vector. A total of 25 values of λ were prepared at equal intervals from 0 to λ<sub>max</sub>, and the λ was determined according to the one standard error rule in which we selected the largest λ within the standard deviation of the minimum prediction error (among all λ) [<xref rid="pbio.3000966.ref027" ref-type="bibr">27</xref>]. The mean classifier output value (diagnostic probability) was considered indicative of the classifier output. Diagnostic probability values of &gt;0.5 were considered indicative of patients with MDD. We calculated the AUC using the “<italic>perfcurve</italic>” function in MATLAB. In addition, we calculated the accuracy, sensitivity, specificity, PPV, and NPV. Furthermore, we evaluated classifier performance for the unbalanced dataset using the MCC [<xref rid="pbio.3000966.ref042" ref-type="bibr">42</xref>,<xref rid="pbio.3000966.ref043" ref-type="bibr">43</xref>], which takes into account the ratio of the confusion matrix size.</p>
      </sec>
      <sec id="sec021">
        <title>Generalization performance of the classifier</title>
        <p>We tested the generalizability of the network marker using an independent validation dataset. We created 100 classifiers of MDD (10-fold CV × 10 subsamples); therefore, we applied all trained classifiers to the independent validation dataset. Next, we averaged the 100 outputs (diagnostic probability) for each participant and considered the participant to be a patient with MDD if the averaged diagnostic probability value was &gt;0.5.</p>
        <p>To test the statistical significance of the MDD classifier performance, we performed a permutation test. We permuted the diagnostic labels of the discovery dataset and conducted a 10-fold CV and 10-subsampling procedure. Next, we took an average of the 100 outputs (diagnostic probability); a mean diagnostic probability value of &gt;0.5 was considered indicative of a diagnosis of MDD. We repeated this permutation procedure 100 times and calculated the AUC and MCC as the performance metrics of each permutation.</p>
      </sec>
      <sec id="sec022">
        <title>Identification of the important FCs linked to diagnosis</title>
        <p>We examined important resting-state FC for an MDD diagnosis. Briefly, we counted the number of times an FC was selected by LASSO during the 10-fold CV. We considered that this FC was important if this number was significantly higher than chance, according to a permutation test. We permuted the diagnostic labels of the discovery dataset and conducted a 10-fold CV and 10-subsampling procedure and repeated this permutation procedure 100 times. We then used the number of counts for each connection selected by the sparse algorithm during 10-fold CVs × 10 subsamplings (max 100 times) as a statistic in every permutation dataset. To control for the multiple comparison problem, we set a null distribution as the max distribution of the number of counts over all functional connections and set our statistical significance to a certain threshold (<italic>P</italic> &lt; 0.05, 1-sided). FCs selected ≥17 times out of a total of 100 times were regarded as diagnostically important.</p>
      </sec>
    </sec>
    <sec sec-type="supplementary-material" id="sec023">
      <title>Supporting information</title>
      <supplementary-material content-type="local-data" id="pbio.3000966.s001">
        <label>S1 Data</label>
        <caption>
          <title>Excel spreadsheet containing, in separate sheets, the underlying numerical data for Figs <xref ref-type="fig" rid="pbio.3000966.g001">1</xref>, <xref ref-type="fig" rid="pbio.3000966.g003">3A–3D</xref>, <xref ref-type="fig" rid="pbio.3000966.g005">5A and 5B</xref>, and all Supporting information figures.</title>
          <p>(XLSX)</p>
        </caption>
        <media xlink:href="pbio.3000966.s001.xlsx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pbio.3000966.s002">
        <label>S1 Text</label>
        <caption>
          <title>Prediction performance using SVM.</title>
          <p>(DOCX)</p>
        </caption>
        <media xlink:href="pbio.3000966.s002.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pbio.3000966.s003">
        <label>S2 Text</label>
        <caption>
          <title>Analysis and validation of controls for confound artifact.</title>
          <p>(DOCX)</p>
        </caption>
        <media xlink:href="pbio.3000966.s003.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pbio.3000966.s004">
        <label>S3 Text</label>
        <caption>
          <title>Utility of harmonization.</title>
          <p>(DOCX)</p>
        </caption>
        <media xlink:href="pbio.3000966.s004.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pbio.3000966.s005">
        <label>S4 Text</label>
        <caption>
          <title>Differences in prediction performance among imaging sites.</title>
          <p>(DOCX)</p>
        </caption>
        <media xlink:href="pbio.3000966.s005.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pbio.3000966.s006">
        <label>S5 Text</label>
        <caption>
          <title>Higher/lower resolution of regions of interest.</title>
          <p>(DOCX)</p>
        </caption>
        <media xlink:href="pbio.3000966.s006.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pbio.3000966.s007">
        <label>S6 Text</label>
        <caption>
          <title>Generalization of the classifiers to other disorders.</title>
          <p>(DOCX)</p>
        </caption>
        <media xlink:href="pbio.3000966.s007.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pbio.3000966.s008">
        <label>S1 Fig</label>
        <caption>
          <title>Distribution of prediction performance and difference in mean age between MDD and HC across all subsamples.</title>
          <p>The distribution of the AUC and <italic>t</italic>-value (difference in mean age between MDD and HC groups) across all subsamples. The numerical data used in this figure are included in <xref ref-type="supplementary-material" rid="pbio.3000966.s001">S1 Data</xref>. AUC, area under the curve; HC, healthy control; MDD, major depressive disorder.</p>
          <p>(TIF)</p>
        </caption>
        <media xlink:href="pbio.3000966.s008.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pbio.3000966.s009">
        <label>S2 Fig</label>
        <caption>
          <title>Comparing the prediction performances among harmonization schemes.</title>
          <p>(<bold>a</bold>) The prediction performance (AUC) of the MDD classifier in the independent validation dataset for each harmonization scheme for the discovery dataset and the independent validation dataset (without harmonization; blue bar, ComBat harmonization; yellow bar). (<bold>b</bold>) Probability distributions for the diagnosis of MDD in the data from OpenNeuro (OTHER) without harmonization or with ComBat harmonization. The numerical data used in this figure are included in <xref ref-type="supplementary-material" rid="pbio.3000966.s001">S1 Data</xref>. AUC, area under the curve; HC, healthy control; MCC, Matthews correlation coefficient; MDD, major depressive disorder.</p>
          <p>(TIF)</p>
        </caption>
        <media xlink:href="pbio.3000966.s009.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pbio.3000966.s010">
        <label>S3 Fig</label>
        <caption>
          <title>Bootstrap prediction performances in the independent validation dataset.</title>
          <p>Prediction performances of the MDD classifier in the independent validation dataset in each site. Each color bar indicates a site. Error bar shows the 95% confidence interval from the bootstrap. The numerical data used in this figure are included in <xref ref-type="supplementary-material" rid="pbio.3000966.s001">S1 Data</xref>. AUC, area under the curve; HKH, Hiroshima Kajikawa Hospital; HRC, Hiroshima Rehabilitation Center; HUH, Hiroshima University Hospital; MDD, major depressive disorder; UYA, Yamaguchi University.</p>
          <p>(TIF)</p>
        </caption>
        <media xlink:href="pbio.3000966.s010.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pbio.3000966.s011">
        <label>S4 Fig</label>
        <caption>
          <title>Higher/lower resolution of regions of interest.</title>
          <p>The prediction performances (AUC, accuracy, specificity, and sensitivity) of the MDD classifier constructed by Schaefer’s ROIs as a function of the number of ROIs. The numerical data used in this figure are included in <xref ref-type="supplementary-material" rid="pbio.3000966.s001">S1 Data</xref>. AUC, area under the curve; MDD, major depressive disorder; ROI, region of interest.</p>
          <p>(TIF)</p>
        </caption>
        <media xlink:href="pbio.3000966.s011.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pbio.3000966.s012">
        <label>S5 Fig</label>
        <caption>
          <title>Generalization of the classifiers to other psychiatric disorders.</title>
          <p>Density distributions of the probability of diagnosis obtained by applying (a) the MDD marker, (b) SCZ marker, and (c) ASD marker to the HCs and patients with MDD, SCZ, and ASD. In each panel, the patient distribution and the HC distribution are plotted separately, with the colored areas representing one or the other. The numbers in parentheses next to HC, MDD, ASD, and SCZ in each panel indicate the number of subjects in the distributions. The independent validation dataset was used in a and b. HCs in a, b, and c were scanned at the same sites as their corresponding patient data. The numerical data used in this figure are included in <xref ref-type="supplementary-material" rid="pbio.3000966.s001">S1 Data</xref>. ASD, autism spectrum disorder; HC, healthy control; MDD, major depressive disorder; SCZ, schizophrenia.</p>
          <p>(TIF)</p>
        </caption>
        <media xlink:href="pbio.3000966.s012.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pbio.3000966.s013">
        <label>S1 Table</label>
        <caption>
          <title>Imaging protocols for resting-state fMRI in both datasets.</title>
          <p>(XLSX)</p>
        </caption>
        <media xlink:href="pbio.3000966.s013.xlsx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pbio.3000966.s014">
        <label>S2 Table</label>
        <caption>
          <title>Clinical characteristics of major depressive disorder patients in the discovery dataset.</title>
          <p>(XLSX)</p>
        </caption>
        <media xlink:href="pbio.3000966.s014.xlsx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pbio.3000966.s015">
        <label>S3 Table</label>
        <caption>
          <title>Imaging protocols for resting-state fMRI in the traveling subject dataset.</title>
          <p>(XLSX)</p>
        </caption>
        <media xlink:href="pbio.3000966.s015.xlsx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pbio.3000966.s016">
        <label>S4 Table</label>
        <caption>
          <title>Prediction performances in the independent validation dataset for different harmonization schemes.</title>
          <p>(XLSX)</p>
        </caption>
        <media xlink:href="pbio.3000966.s016.xlsx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pbio.3000966.s017">
        <label>S5 Table</label>
        <caption>
          <title>Description of important FCs.</title>
          <p>(XLSX)</p>
        </caption>
        <media xlink:href="pbio.3000966.s017.xlsx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pbio.3000966.s018">
        <label>S6 Table</label>
        <caption>
          <title>Demographic characteristics of participants in both datasets.</title>
          <p>(XLSX)</p>
        </caption>
        <media xlink:href="pbio.3000966.s018.xlsx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>AAL</term>
          <def>
            <p>anatomical automatic labeling</p>
          </def>
        </def-item>
        <def-item>
          <term>ASD</term>
          <def>
            <p>autism spectrum disorder</p>
          </def>
        </def-item>
        <def-item>
          <term>AUC</term>
          <def>
            <p>area under the curve</p>
          </def>
        </def-item>
        <def-item>
          <term>BDI-II</term>
          <def>
            <p>Beck Depression Inventory-II</p>
          </def>
        </def-item>
        <def-item>
          <term>BOLD</term>
          <def>
            <p>blood-oxygen-level–dependent</p>
          </def>
        </def-item>
        <def-item>
          <term>CI</term>
          <def>
            <p>confidence interval</p>
          </def>
        </def-item>
        <def-item>
          <term>CREST</term>
          <def>
            <p>Core Research for Evolutional Science and Technology</p>
          </def>
        </def-item>
        <def-item>
          <term>CSF</term>
          <def>
            <p>cerebrospinal fluid</p>
          </def>
        </def-item>
        <def-item>
          <term>DSM</term>
          <def>
            <p>Diagnostic and Statistical Manual of Mental Disorders</p>
          </def>
        </def-item>
        <def-item>
          <term>FC</term>
          <def>
            <p>functional connectivity</p>
          </def>
        </def-item>
        <def-item>
          <term>FD</term>
          <def>
            <p>frame-wise displacement</p>
          </def>
        </def-item>
        <def-item>
          <term>HC</term>
          <def>
            <p>healthy control</p>
          </def>
        </def-item>
        <def-item>
          <term>HCP</term>
          <def>
            <p>Human Connectome Project</p>
          </def>
        </def-item>
        <def-item>
          <term>HKH</term>
          <def>
            <p>Hiroshima Kajikawa Hospital</p>
          </def>
        </def-item>
        <def-item>
          <term>HRC</term>
          <def>
            <p>Hiroshima Rehabilitation Center</p>
          </def>
        </def-item>
        <def-item>
          <term>HUH</term>
          <def>
            <p>Hiroshima University Hospital</p>
          </def>
        </def-item>
        <def-item>
          <term>LASSO</term>
          <def>
            <p>least absolute shrinkage and selection operator</p>
          </def>
        </def-item>
        <def-item>
          <term>MCC</term>
          <def>
            <p>Matthews correlation coefficient</p>
          </def>
        </def-item>
        <def-item>
          <term>MDD</term>
          <def>
            <p>major depressive disorder</p>
          </def>
        </def-item>
        <def-item>
          <term>MNI</term>
          <def>
            <p>Montreal Neurological Institute</p>
          </def>
        </def-item>
        <def-item>
          <term>NPV</term>
          <def>
            <p>negative predictive value</p>
          </def>
        </def-item>
        <def-item>
          <term>PPV</term>
          <def>
            <p>positive predictive value</p>
          </def>
        </def-item>
        <def-item>
          <term>RDoC</term>
          <def>
            <p>Research Domain Criteria</p>
          </def>
        </def-item>
        <def-item>
          <term>ROI</term>
          <def>
            <p>region of interest</p>
          </def>
        </def-item>
        <def-item>
          <term>rs-fMRI</term>
          <def>
            <p>resting-state functional magnetic resonance imaging</p>
          </def>
        </def-item>
        <def-item>
          <term>rTMS</term>
          <def>
            <p>repetitive transcranial magnetic stimulation</p>
          </def>
        </def-item>
        <def-item>
          <term>SCID</term>
          <def>
            <p>Structured Clinical Interview for DSM</p>
          </def>
        </def-item>
        <def-item>
          <term>SCZ</term>
          <def>
            <p>schizophrenia</p>
          </def>
        </def-item>
        <def-item>
          <term>SRPBS</term>
          <def>
            <p>Strategic Research Program for Brain Science</p>
          </def>
        </def-item>
        <def-item>
          <term>SVM</term>
          <def>
            <p>support vector machine</p>
          </def>
        </def-item>
        <def-item>
          <term>UYA</term>
          <def>
            <p>Yamaguchi University</p>
          </def>
        </def-item>
        <def-item>
          <term>WM</term>
          <def>
            <p>white matter</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ref-list>
      <title>References</title>
      <ref id="pbio.3000966.ref001">
        <label>1</label>
        <mixed-citation publication-type="journal"><name><surname>Hyman</surname><given-names>SE</given-names></name>. <article-title>A glimmer of light for neuropsychiatric disorders</article-title>. <source>Nature</source>. <year>2008</year>;<volume>455</volume>(<issue>7215</issue>):<fpage>890</fpage>–<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1038/nature07454</pub-id>
<pub-id pub-id-type="pmid">18923510</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref002">
        <label>2</label>
        <mixed-citation publication-type="journal"><name><surname>Miller</surname><given-names>G</given-names></name>. <article-title>Beyond DSM: seeking a brain-based classification of mental illness</article-title>. <source>American Association for the Advancement of Science</source>. <year>2010</year>
<pub-id pub-id-type="doi">10.1126/science.327.5972.1437</pub-id>
<pub-id pub-id-type="pmid">20299556</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref003">
        <label>3</label>
        <mixed-citation publication-type="journal"><name><surname>Insel</surname><given-names>TR</given-names></name>, <name><surname>Cuthbert</surname><given-names>BN</given-names></name>. <article-title>Brain disorders? Precisely</article-title>. <source>Science</source>. <year>2015</year>;<volume>348</volume>(<issue>6234</issue>):<fpage>499</fpage>–<lpage>500</lpage>. <pub-id pub-id-type="doi">10.1126/science.aab2358</pub-id>
<pub-id pub-id-type="pmid">25931539</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref004">
        <label>4</label>
        <mixed-citation publication-type="journal"><name><surname>Goodkind</surname><given-names>M</given-names></name>, <name><surname>Eickhoff</surname><given-names>SB</given-names></name>, <name><surname>Oathes</surname><given-names>DJ</given-names></name>, <name><surname>Jiang</surname><given-names>Y</given-names></name>, <name><surname>Chang</surname><given-names>A</given-names></name>, <name><surname>Jones-Hagata</surname><given-names>LB</given-names></name>, <etal>et al</etal>
<article-title>Identification of a common neurobiological substrate for mental illness</article-title>. <source>JAMA Psychiatry</source>. <year>2015</year>;<volume>72</volume>(<issue>4</issue>):<fpage>305</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2014.2206</pub-id>
<pub-id pub-id-type="pmid">25651064</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref005">
        <label>5</label>
        <mixed-citation publication-type="journal"><name><surname>Jacobi</surname><given-names>F</given-names></name>, <name><surname>Wittchen</surname><given-names>HU</given-names></name>, <name><surname>Holting</surname><given-names>C</given-names></name>, <name><surname>Hofler</surname><given-names>M</given-names></name>, <name><surname>Pfister</surname><given-names>H</given-names></name>, <name><surname>Muller</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS)</article-title>. <source>Psychol Med</source>. <year>2004</year>;<volume>34</volume>(<issue>4</issue>):<fpage>597</fpage>–<lpage>611</lpage>. <pub-id pub-id-type="doi">10.1017/S0033291703001399</pub-id> .<pub-id pub-id-type="pmid">15099415</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref006">
        <label>6</label>
        <mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>SH</given-names></name>, <name><surname>Ripke</surname><given-names>S</given-names></name>, <name><surname>Neale</surname><given-names>BM</given-names></name>, <name><surname>Faraone</surname><given-names>SV</given-names></name>, <name><surname>Purcell</surname><given-names>SM</given-names></name>, <name><surname>Perlis</surname><given-names>RH</given-names></name>, <etal>et al</etal>
<article-title>Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs</article-title>. <source>Nat Genet</source>. <year>2013</year>;<volume>45</volume>(<issue>9</issue>):<fpage>984</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2711</pub-id>
<pub-id pub-id-type="pmid">23933821</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref007">
        <label>7</label>
        <mixed-citation publication-type="journal"><name><surname>McTeague</surname><given-names>LM</given-names></name>, <name><surname>Huemer</surname><given-names>J</given-names></name>, <name><surname>Carreon</surname><given-names>DM</given-names></name>, <name><surname>Jiang</surname><given-names>Y</given-names></name>, <name><surname>Eickhoff</surname><given-names>SB</given-names></name>, <name><surname>Etkin</surname><given-names>A</given-names></name>. <article-title>Identification of Common Neural Circuit Disruptions in Cognitive Control Across Psychiatric Disorders</article-title>. <source>Am J Psychiatry</source>. <year>2017</year>;<volume>174</volume>(<issue>7</issue>):<fpage>676</fpage>–<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2017.16040400</pub-id>
<pub-id pub-id-type="pmid">28320224</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref008">
        <label>8</label>
        <mixed-citation publication-type="journal"><name><surname>Biswal</surname><given-names>BB</given-names></name>, <name><surname>Mennes</surname><given-names>M</given-names></name>, <name><surname>Zuo</surname><given-names>XN</given-names></name>, <name><surname>Gohel</surname><given-names>S</given-names></name>, <name><surname>Kelly</surname><given-names>C</given-names></name>, <name><surname>Smith</surname><given-names>SM</given-names></name>, <etal>et al</etal>
<article-title>Toward discovery science of human brain function</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2010</year>;<volume>107</volume>(<issue>10</issue>):<fpage>4734</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0911855107</pub-id>
<pub-id pub-id-type="pmid">20176931</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref009">
        <label>9</label>
        <mixed-citation publication-type="journal"><name><surname>Xia</surname><given-names>M</given-names></name>, <name><surname>He</surname><given-names>Y</given-names></name>. <article-title>Functional connectomics from a "big data" perspective</article-title>. <source>Neuroimage</source>. <year>2017</year>;<volume>160</volume>:<fpage>152</fpage>–<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2017.02.031</pub-id> .<pub-id pub-id-type="pmid">28232122</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref010">
        <label>10</label>
        <mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>SM</given-names></name>, <name><surname>Vidaurre</surname><given-names>D</given-names></name>, <name><surname>Beckmann</surname><given-names>CF</given-names></name>, <name><surname>Glasser</surname><given-names>MF</given-names></name>, <name><surname>Jenkinson</surname><given-names>M</given-names></name>, <name><surname>Miller</surname><given-names>KL</given-names></name>, <etal>et al</etal>
<article-title>Functional connectomics from resting-state fMRI</article-title>. <source>Trends Cogn Sci</source>. <year>2013</year>;<volume>17</volume>(<issue>12</issue>):<fpage>666</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.tics.2013.09.016</pub-id>
<pub-id pub-id-type="pmid">24238796</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref011">
        <label>11</label>
        <mixed-citation publication-type="journal"><name><surname>Clementz</surname><given-names>BA</given-names></name>, <name><surname>Sweeney</surname><given-names>JA</given-names></name>, <name><surname>Hamm</surname><given-names>JP</given-names></name>, <name><surname>Ivleva</surname><given-names>EI</given-names></name>, <name><surname>Ethridge</surname><given-names>LE</given-names></name>, <name><surname>Pearlson</surname><given-names>GD</given-names></name>, <etal>et al</etal>
<article-title>Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers</article-title>. <source>Am J Psychiatry</source>. <year>2016</year>;<volume>173</volume>(<issue>4</issue>):<fpage>373</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2015.14091200</pub-id>
<pub-id pub-id-type="pmid">26651391</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref012">
        <label>12</label>
        <mixed-citation publication-type="journal"><name><surname>Drysdale</surname><given-names>AT</given-names></name>, <name><surname>Grosenick</surname><given-names>L</given-names></name>, <name><surname>Downar</surname><given-names>J</given-names></name>, <name><surname>Dunlop</surname><given-names>K</given-names></name>, <name><surname>Mansouri</surname><given-names>F</given-names></name>, <name><surname>Meng</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Resting-state connectivity biomarkers define neurophysiological subtypes of depression</article-title>. <source>Nat Med</source>. <year>2017</year>;<volume>23</volume>(<issue>1</issue>):<fpage>28</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1038/nm.4246</pub-id>
<pub-id pub-id-type="pmid">27918562</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref013">
        <label>13</label>
        <mixed-citation publication-type="journal"><name><surname>Tokuda</surname><given-names>T</given-names></name>, <name><surname>Yoshimoto</surname><given-names>J</given-names></name>, <name><surname>Shimizu</surname><given-names>Y</given-names></name>, <name><surname>Okada</surname><given-names>G</given-names></name>, <name><surname>Takamura</surname><given-names>M</given-names></name>, <name><surname>Okamoto</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Identification of depression subtypes and relevant brain regions using a data-driven approach</article-title>. <source>Scientific reports</source>. <year>2018</year>;<volume>8</volume>(<issue>1</issue>):<fpage>14082</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-018-32521-z</pub-id>
<pub-id pub-id-type="pmid">30237567</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref014">
        <label>14</label>
        <mixed-citation publication-type="journal"><name><surname>Dinga</surname><given-names>R</given-names></name>, <name><surname>Schmaal</surname><given-names>L</given-names></name>, <name><surname>Penninx</surname><given-names>B</given-names></name>, <name><surname>van Tol</surname><given-names>MJ</given-names></name>, <name><surname>Veltman</surname><given-names>DJ</given-names></name>, <name><surname>van Velzen</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Evaluating the evidence for biotypes of depression: Methodological replication and extension of</article-title>. <source>Neuroimage Clin</source>. <year>2019</year>;<volume>22</volume>:<fpage>101796</fpage>
<pub-id pub-id-type="doi">10.1016/j.nicl.2019.101796</pub-id>
<pub-id pub-id-type="pmid">30935858</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref015">
        <label>15</label>
        <mixed-citation publication-type="journal"><name><surname>Whelan</surname><given-names>R</given-names></name>, <name><surname>Garavan</surname><given-names>H</given-names></name>. <article-title>When optimism hurts: inflated predictions in psychiatric neuroimaging</article-title>. <source>Biol Psychiatry</source>. <year>2014</year>;<volume>75</volume>(<issue>9</issue>):<fpage>746</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2013.05.014</pub-id> .<pub-id pub-id-type="pmid">23778288</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref016">
        <label>16</label>
        <mixed-citation publication-type="journal"><name><surname>Ichikawa</surname><given-names>N</given-names></name>, <name><surname>Lisi</surname><given-names>G</given-names></name>, <name><surname>Yahata</surname><given-names>N</given-names></name>, <name><surname>Okada</surname><given-names>G</given-names></name>, <name><surname>Takamura</surname><given-names>M</given-names></name>, <name><surname>Hashimoto</surname><given-names>RI</given-names></name>, <etal>et al</etal>
<article-title>Primary functional brain connections associated with melancholic major depressive disorder and modulation by antidepressants</article-title>. <source>Scientific reports</source>. <year>2020</year>;<volume>10</volume>(<issue>1</issue>):<fpage>3542</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-020-60527-z</pub-id>
<pub-id pub-id-type="pmid">32103088</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref017">
        <label>17</label>
        <mixed-citation publication-type="journal"><name><surname>Yahata</surname><given-names>N</given-names></name>, <name><surname>Morimoto</surname><given-names>J</given-names></name>, <name><surname>Hashimoto</surname><given-names>R</given-names></name>, <name><surname>Lisi</surname><given-names>G</given-names></name>, <name><surname>Shibata</surname><given-names>K</given-names></name>, <name><surname>Kawakubo</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>A small number of abnormal brain connections predicts adult autism spectrum disorder</article-title>. <source>Nat Commun</source>. <year>2016</year>;<volume>7</volume>:<fpage>11254</fpage> Epub 2016/04/15. <pub-id pub-id-type="doi">10.1038/ncomms11254</pub-id>
<pub-id pub-id-type="pmid">27075704</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref018">
        <label>18</label>
        <mixed-citation publication-type="journal"><name><surname>Yoshihara</surname><given-names>Y</given-names></name>, <name><surname>Lisi</surname><given-names>G</given-names></name>, <name><surname>Yahata</surname><given-names>N</given-names></name>, <name><surname>Fujino</surname><given-names>J</given-names></name>, <name><surname>Matsumoto</surname><given-names>Y</given-names></name>, <name><surname>Miyata</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Overlapping but Asymmetrical Relationships Between Schizophrenia and Autism Revealed by Brain Connectivity</article-title>. <source>Schizophr Bull</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1093/schbul/sbaa021</pub-id> .<pub-id pub-id-type="pmid">32300809</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref019">
        <label>19</label>
        <mixed-citation publication-type="other">Kashiwagi Y, Tokuda T, Takahara Y, Sakai Y, Yoshimoto J, Yamashita A, Yoshioka T, et al. editors. Reproducible stratification of major depressive patients by multi-dimensional data-driven approach based on resting-state functional connectivity. 33rd European College of Neuropsychopharmacology Congress 2020; Virtual.</mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref020">
        <label>20</label>
        <mixed-citation publication-type="journal"><name><surname>Munafò</surname><given-names>MR</given-names></name>, <name><surname>Nosek</surname><given-names>BA</given-names></name>, <name><surname>Bishop</surname><given-names>DVM</given-names></name>, <name><surname>Button</surname><given-names>KS</given-names></name>, <name><surname>Chambers</surname><given-names>CD</given-names></name>, <name><surname>Percie du Sert</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>A manifesto for reproducible science</article-title>. <source>Nature Human Behaviour</source>. <year>2017</year>;<volume>1</volume>(<issue>1</issue>):<fpage>0021</fpage>
<pub-id pub-id-type="doi">10.1038/s41562-016-0021</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref021">
        <label>21</label>
        <mixed-citation publication-type="journal"><name><surname>Nosek</surname><given-names>BA</given-names></name>, <name><surname>Errington</surname><given-names>TM</given-names></name>. <article-title>Making sense of replications</article-title>. <source>Elife</source>. <year>2017</year>;<fpage>6</fpage>
<pub-id pub-id-type="doi">10.7554/eLife.23383</pub-id>
<pub-id pub-id-type="pmid">28100398</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref022">
        <label>22</label>
        <mixed-citation publication-type="journal"><name><surname>Poldrack</surname><given-names>RA</given-names></name>, <name><surname>Baker</surname><given-names>CI</given-names></name>, <name><surname>Durnez</surname><given-names>J</given-names></name>, <name><surname>Gorgolewski</surname><given-names>KJ</given-names></name>, <name><surname>Matthews</surname><given-names>PM</given-names></name>, <name><surname>Munafo</surname><given-names>MR</given-names></name>, <etal>et al</etal>
<article-title>Scanning the horizon: towards transparent and reproducible neuroimaging research</article-title>. <source>Nat Rev Neurosci</source>. <year>2017</year>;<volume>18</volume>(<issue>2</issue>):<fpage>115</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1038/nrn.2016.167</pub-id> .<pub-id pub-id-type="pmid">28053326</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref023">
        <label>23</label>
        <mixed-citation publication-type="journal"><name><surname>He</surname><given-names>Y</given-names></name>, <name><surname>Byrge</surname><given-names>L</given-names></name>, <name><surname>Kennedy</surname><given-names>DP</given-names></name>. <article-title>Nonreplication of functional connectivity differences in autism spectrum disorder across multiple sites and denoising strategies</article-title>. <source>Hum Brain Mapp</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1002/hbm.24879</pub-id> .<pub-id pub-id-type="pmid">31916675</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref024">
        <label>24</label>
        <mixed-citation publication-type="journal"><name><surname>Ferrari</surname><given-names>AJ</given-names></name>, <name><surname>Charlson</surname><given-names>FJ</given-names></name>, <name><surname>Norman</surname><given-names>RE</given-names></name>, <name><surname>Patten</surname><given-names>SB</given-names></name>, <name><surname>Freedman</surname><given-names>G</given-names></name>, <name><surname>Murray</surname><given-names>CJ</given-names></name>, <etal>et al</etal>
<article-title>Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010</article-title>. <source>PLoS Med</source>. <year>2013</year>;<volume>10</volume>(<issue>11</issue>):<fpage>e1001547</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pmed.1001547</pub-id>
<pub-id pub-id-type="pmid">24223526</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref025">
        <label>25</label>
        <mixed-citation publication-type="journal"><name><surname>Hay</surname><given-names>SI</given-names></name>, <name><surname>Abajobir</surname><given-names>AA</given-names></name>, <name><surname>Abate</surname><given-names>KH</given-names></name>, <name><surname>Abbafati</surname><given-names>C</given-names></name>, <name><surname>Abbas</surname><given-names>KM</given-names></name>, <name><surname>Abd-Allah</surname><given-names>F</given-names></name>, <etal>et al</etal>
<article-title>Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016</article-title>. <source>The Lancet</source>. <year>2017</year>;<volume>390</volume>(<issue>10100</issue>):<fpage>1260</fpage>–<lpage>344</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(17)32130-X</pub-id>
<pub-id pub-id-type="pmid">28919118</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref026">
        <label>26</label>
        <mixed-citation publication-type="journal"><name><surname>Yamashita</surname><given-names>A</given-names></name>, <name><surname>Yahata</surname><given-names>N</given-names></name>, <name><surname>Itahashi</surname><given-names>T</given-names></name>, <name><surname>Lisi</surname><given-names>G</given-names></name>, <name><surname>Yamada</surname><given-names>T</given-names></name>, <name><surname>Ichikawa</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>Harmonization of resting-state functional MRI data across multiple imaging sites via the separation of site differences into sampling bias and measurement bias</article-title>. <source>PLoS Biol</source>. <year>2019</year>;<volume>17</volume>(<issue>4</issue>):<fpage>e3000042</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pbio.3000042</pub-id>
<pub-id pub-id-type="pmid">30998673</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref027">
        <label>27</label>
        <mixed-citation publication-type="book"><name><surname>Hastie</surname><given-names>T</given-names></name>, <name><surname>Tibshirani</surname><given-names>R</given-names></name>, <name><surname>Wainwright</surname><given-names>M</given-names></name>. <source>Statistical learning with sparsity: the lasso and generalizations</source>. <publisher-name>Chapman and Hall/CRC</publisher-name>; <year>2015</year>.</mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref028">
        <label>28</label>
        <mixed-citation publication-type="journal"><name><surname>Freedman</surname><given-names>R</given-names></name>, <name><surname>Lewis</surname><given-names>DA</given-names></name>, <name><surname>Michels</surname><given-names>R</given-names></name>, <name><surname>Pine</surname><given-names>DS</given-names></name>, <name><surname>Schultz</surname><given-names>SK</given-names></name>, <name><surname>Tamminga</surname><given-names>CA</given-names></name>, <etal>et al</etal>
<article-title>The initial field trials of DSM-5: new blooms and old thorns</article-title>. <source>Am Psychiatric Assoc</source>. <year>2013</year>
<pub-id pub-id-type="doi">10.1176/appi.ajp.2012.12091189</pub-id>
<pub-id pub-id-type="pmid">23288382</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref029">
        <label>29</label>
        <mixed-citation publication-type="journal"><name><surname>Regier</surname><given-names>DA</given-names></name>, <name><surname>Narrow</surname><given-names>WE</given-names></name>, <name><surname>Clarke</surname><given-names>DE</given-names></name>, <name><surname>Kraemer</surname><given-names>HC</given-names></name>, <name><surname>Kuramoto</surname><given-names>SJ</given-names></name>, <name><surname>Kuhl</surname><given-names>EA</given-names></name>, <etal>et al</etal>
<article-title>DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses</article-title>. <source>American journal of psychiatry</source>. <year>2013</year>;<volume>170</volume>(<issue>1</issue>):<fpage>59</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2012.12070999</pub-id>
<pub-id pub-id-type="pmid">23111466</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref030">
        <label>30</label>
        <mixed-citation publication-type="journal"><name><surname>Shankman</surname><given-names>SA</given-names></name>, <name><surname>Funkhouser</surname><given-names>CJ</given-names></name>, <name><surname>Klein</surname><given-names>DN</given-names></name>, <name><surname>Davila</surname><given-names>J</given-names></name>, <name><surname>Lerner</surname><given-names>D</given-names></name>, <name><surname>Hee</surname><given-names>D</given-names></name>. <article-title>Reliability and validity of severity dimensions of psychopathology assessed using the Structured Clinical Interview for DSM-5 (SCID)</article-title>. <source>Int J Methods Psychiatr Res</source>. <year>2018</year>;<volume>27</volume>(<issue>1</issue>). <pub-id pub-id-type="doi">10.1002/mpr.1590</pub-id>
<pub-id pub-id-type="pmid">29034525</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref031">
        <label>31</label>
        <mixed-citation publication-type="journal"><name><surname>Williams</surname><given-names>JB</given-names></name>, <name><surname>Gibbon</surname><given-names>M</given-names></name>, <name><surname>First</surname><given-names>MB</given-names></name>, <name><surname>Spitzer</surname><given-names>RL</given-names></name>, <name><surname>Davies</surname><given-names>M</given-names></name>, <name><surname>Borus</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>The structured clinical interview for DSM-III-R (SCID): II. Multisite test-retest reliability</article-title>. <source>Archives of General Psychiatry</source>. <year>1992</year>;<volume>49</volume>(<issue>8</issue>):<fpage>630</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.1992.01820080038006</pub-id>
<pub-id pub-id-type="pmid">1637253</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref032">
        <label>32</label>
        <mixed-citation publication-type="journal"><name><surname>Otsubo</surname><given-names>T</given-names></name>, <name><surname>Tanaka</surname><given-names>K</given-names></name>, <name><surname>Koda</surname><given-names>R</given-names></name>, <name><surname>Shinoda</surname><given-names>J</given-names></name>, <name><surname>Sano</surname><given-names>N</given-names></name>, <name><surname>Tanaka</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Reliability and validity of Japanese version of the Mini-International Neuropsychiatric Interview</article-title>. <source>Psychiatry and clinical neurosciences</source>. <year>2005</year>;<volume>59</volume>(<issue>5</issue>):<fpage>517</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1111/j.1440-1819.2005.01408.x</pub-id>
<pub-id pub-id-type="pmid">16194252</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref033">
        <label>33</label>
        <mixed-citation publication-type="journal"><name><surname>Phillips</surname><given-names>ML</given-names></name>, <name><surname>Kupfer</surname><given-names>DJ</given-names></name>. <article-title>Bipolar disorder diagnosis: challenges and future directions</article-title>. <source>The Lancet</source>. <year>2013</year>;<volume>381</volume>(<issue>9878</issue>):<fpage>1663</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(13)60989-7</pub-id>
<pub-id pub-id-type="pmid">23663952</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref034">
        <label>34</label>
        <mixed-citation publication-type="journal"><name><surname>Glasser</surname><given-names>MF</given-names></name>, <name><surname>Coalson</surname><given-names>TS</given-names></name>, <name><surname>Robinson</surname><given-names>EC</given-names></name>, <name><surname>Hacker</surname><given-names>CD</given-names></name>, <name><surname>Harwell</surname><given-names>J</given-names></name>, <name><surname>Yacoub</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>A multi-modal parcellation of human cerebral cortex</article-title>. <source>Nature</source>. <year>2016</year>;<volume>536</volume>(<issue>7615</issue>):<fpage>171</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/nature18933</pub-id>
<pub-id pub-id-type="pmid">27437579</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref035">
        <label>35</label>
        <mixed-citation publication-type="journal"><name><surname>Fortin</surname><given-names>JP</given-names></name>, <name><surname>Cullen</surname><given-names>N</given-names></name>, <name><surname>Sheline</surname><given-names>YI</given-names></name>, <name><surname>Taylor</surname><given-names>WD</given-names></name>, <name><surname>Aselcioglu</surname><given-names>I</given-names></name>, <name><surname>Cook</surname><given-names>PA</given-names></name>, <etal>et al</etal>
<article-title>Harmonization of cortical thickness measurements across scanners and sites</article-title>. <source>Neuroimage</source>. <year>2018</year>;<volume>167</volume>:<fpage>104</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2017.11.024</pub-id>
<pub-id pub-id-type="pmid">29155184</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref036">
        <label>36</label>
        <mixed-citation publication-type="journal"><name><surname>Fortin</surname><given-names>JP</given-names></name>, <name><surname>Parker</surname><given-names>D</given-names></name>, <name><surname>Tunc</surname><given-names>B</given-names></name>, <name><surname>Watanabe</surname><given-names>T</given-names></name>, <name><surname>Elliott</surname><given-names>MA</given-names></name>, <name><surname>Ruparel</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>Harmonization of multi-site diffusion tensor imaging data</article-title>. <source>Neuroimage</source>. <year>2017</year>;<volume>161</volume>:<fpage>149</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2017.08.047</pub-id>
<pub-id pub-id-type="pmid">28826946</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref037">
        <label>37</label>
        <mixed-citation publication-type="journal"><name><surname>Johnson</surname><given-names>WE</given-names></name>, <name><surname>Li</surname><given-names>C</given-names></name>, <name><surname>Rabinovic</surname><given-names>A</given-names></name>. <article-title>Adjusting batch effects in microarray expression data using empirical Bayes methods</article-title>. <source>Biostatistics</source>. <year>2007</year>;<volume>8</volume>(<issue>1</issue>):<fpage>118</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1093/biostatistics/kxj037</pub-id> .<pub-id pub-id-type="pmid">16632515</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref038">
        <label>38</label>
        <mixed-citation publication-type="journal"><name><surname>Yu</surname><given-names>M</given-names></name>, <name><surname>Linn</surname><given-names>KA</given-names></name>, <name><surname>Cook</surname><given-names>PA</given-names></name>, <name><surname>Phillips</surname><given-names>ML</given-names></name>, <name><surname>McInnis</surname><given-names>M</given-names></name>, <name><surname>Fava</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Statistical harmonization corrects site effects in functional connectivity measurements from multi-site fMRI data</article-title>. <source>Hum Brain Mapp</source>. <year>2018</year>
<pub-id pub-id-type="doi">10.1002/hbm.24241</pub-id> .<pub-id pub-id-type="pmid">29962049</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref039">
        <label>39</label>
        <mixed-citation publication-type="journal"><name><surname>Takagi</surname><given-names>Y</given-names></name>, <name><surname>Sakai</surname><given-names>Y</given-names></name>, <name><surname>Lisi</surname><given-names>G</given-names></name>, <name><surname>Yahata</surname><given-names>N</given-names></name>, <name><surname>Abe</surname><given-names>Y</given-names></name>, <name><surname>Nishida</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>A Neural Marker of Obsessive-Compulsive Disorder from Whole-Brain Functional Connectivity</article-title>. <source>Scientific Reports</source>. <year>2017</year>;<volume>7</volume>(<issue>1</issue>):<fpage>7538</fpage> Epub 2017/08/10. <pub-id pub-id-type="doi">10.1038/s41598-017-07792-7</pub-id>
<pub-id pub-id-type="pmid">28790433</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref040">
        <label>40</label>
        <mixed-citation publication-type="journal"><name><surname>Tibshirani</surname><given-names>R</given-names></name>. <article-title>Regression Shrinkage and Selection via the Lasso</article-title>. <source>Journal of the Royal Statistical Society Series B (Methodological)</source>. <year>1996</year>;<volume>58</volume>(<issue>1</issue>):<fpage>267</fpage>–<lpage>88</lpage>.</mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref041">
        <label>41</label>
        <mixed-citation publication-type="journal"><name><surname>Wallace</surname><given-names>BC</given-names></name>, <name><surname>Small</surname><given-names>K</given-names></name>, <name><surname>Brodley</surname><given-names>CE</given-names></name>, <name><surname>Trikalinos</surname><given-names>TA</given-names></name>. <source>Class Imbalance, Redux</source>. <volume>2011</volume>:<fpage>754</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1109/icdm.2011.33</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref042">
        <label>42</label>
        <mixed-citation publication-type="journal"><name><surname>Chicco</surname><given-names>D</given-names></name>. <article-title>Ten quick tips for machine learning in computational biology</article-title>. <source>BioData Min</source>. <year>2017</year>;<volume>10</volume>:<fpage>35</fpage>
<pub-id pub-id-type="doi">10.1186/s13040-017-0155-3</pub-id>
<pub-id pub-id-type="pmid">29234465</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref043">
        <label>43</label>
        <mixed-citation publication-type="journal"><name><surname>Matthews</surname><given-names>BW</given-names></name>. <article-title>Comparison of the predicted and observed secondary structure of T4 phage lysozyme</article-title>. <source>Biochimica et Biophysica Acta (BBA)—Protein Structure</source>. <year>1975</year>;<volume>405</volume>(<issue>2</issue>):<fpage>442</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/0005-2795(75)90109-9</pub-id>
<pub-id pub-id-type="pmid">1180967</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref044">
        <label>44</label>
        <mixed-citation publication-type="journal"><name><surname>Kohoutova</surname><given-names>L</given-names></name>, <name><surname>Heo</surname><given-names>J</given-names></name>, <name><surname>Cha</surname><given-names>S</given-names></name>, <name><surname>Lee</surname><given-names>S</given-names></name>, <name><surname>Moon</surname><given-names>T</given-names></name>, <name><surname>Wager</surname><given-names>TD</given-names></name>, <etal>et al</etal>
<article-title>Toward a unified framework for interpreting machine-learning models in neuroimaging</article-title>. <source>Nat Protoc. 2020</source>;<volume>15</volume>(<issue>4</issue>):<fpage>1399</fpage>–<lpage>435</lpage>. <pub-id pub-id-type="doi">10.1038/s41596-019-0289-5</pub-id> .<pub-id pub-id-type="pmid">32203486</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref045">
        <label>45</label>
        <mixed-citation publication-type="journal"><name><surname>Akobeng</surname><given-names>AK</given-names></name>. <article-title>Understanding diagnostic tests 3: Receiver operating characteristic curves</article-title>. <source>Acta Paediatr</source>. <year>2007</year>;<volume>96</volume>(<issue>5</issue>):<fpage>644</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/j.1651-2227.2006.00178.x</pub-id> .<pub-id pub-id-type="pmid">17376185</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref046">
        <label>46</label>
        <mixed-citation publication-type="journal"><name><surname>He</surname><given-names>Y</given-names></name>, <name><surname>Byrge</surname><given-names>L</given-names></name>, <name><surname>Kennedy</surname><given-names>DP</given-names></name>. <article-title>Non-replication of functional connectivity differences in ASD: a multi-site study</article-title>. <source>bioRxiv</source>. <year>2019</year>:<fpage>640797</fpage>
<pub-id pub-id-type="doi">10.1101/640797</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref047">
        <label>47</label>
        <mixed-citation publication-type="journal"><name><surname>Yin</surname><given-names>Z</given-names></name>, <name><surname>Chang</surname><given-names>M</given-names></name>, <name><surname>Wei</surname><given-names>S</given-names></name>, <name><surname>Jiang</surname><given-names>X</given-names></name>, <name><surname>Zhou</surname><given-names>Y</given-names></name>, <name><surname>Cui</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Decreased Functional Connectivity in Insular Subregions in Depressive Episodes of Bipolar Disorder and Major Depressive Disorder</article-title>. <source>Front Neurosci</source>. <year>2018</year>;<volume>12</volume>:<fpage>842</fpage>
<pub-id pub-id-type="doi">10.3389/fnins.2018.00842</pub-id>
<pub-id pub-id-type="pmid">30487732</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref048">
        <label>48</label>
        <mixed-citation publication-type="journal"><name><surname>Sliz</surname><given-names>D</given-names></name>, <name><surname>Hayley</surname><given-names>S</given-names></name>. <article-title>Major depressive disorder and alterations in insular cortical activity: a review of current functional magnetic imaging research</article-title>. <source>Front Hum Neurosci</source>. <year>2012</year>;<volume>6</volume>:<fpage>323</fpage>
<pub-id pub-id-type="doi">10.3389/fnhum.2012.00323</pub-id>
<pub-id pub-id-type="pmid">23227005</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref049">
        <label>49</label>
        <mixed-citation publication-type="journal"><name><surname>Mayberg</surname><given-names>HS</given-names></name>, <name><surname>Lozano</surname><given-names>AM</given-names></name>, <name><surname>Voon</surname><given-names>V</given-names></name>, <name><surname>McNeely</surname><given-names>HE</given-names></name>, <name><surname>Seminowicz</surname><given-names>D</given-names></name>, <name><surname>Hamani</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Deep brain stimulation for treatment-resistant depression</article-title>. <source>Neuron</source>. <year>2005</year>;<volume>45</volume>(<issue>5</issue>):<fpage>651</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2005.02.014</pub-id> .<pub-id pub-id-type="pmid">15748841</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref050">
        <label>50</label>
        <mixed-citation publication-type="journal"><name><surname>Fox</surname><given-names>MD</given-names></name>, <name><surname>Buckner</surname><given-names>RL</given-names></name>, <name><surname>White</surname><given-names>MP</given-names></name>, <name><surname>Greicius</surname><given-names>MD</given-names></name>, <name><surname>Pascual-Leone</surname><given-names>A</given-names></name>. <article-title>Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate</article-title>. <source>Biol Psychiatry</source>. <year>2012</year>;<volume>72</volume>(<issue>7</issue>):<fpage>595</fpage>–<lpage>603</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2012.04.028</pub-id>
<pub-id pub-id-type="pmid">22658708</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref051">
        <label>51</label>
        <mixed-citation publication-type="journal"><name><surname>Barch</surname><given-names>DM</given-names></name>, <name><surname>Pagliaccio</surname><given-names>D</given-names></name>, <name><surname>Luking</surname><given-names>K</given-names></name>. <article-title>Mechanisms Underlying Motivational Deficits in Psychopathology: Similarities and Differences in Depression and Schizophrenia</article-title>. <source>Curr Top Behav Neurosci</source>. <year>2016</year>;<volume>27</volume>:<fpage>411</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1007/7854_2015_376</pub-id> .<pub-id pub-id-type="pmid">26026289</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref052">
        <label>52</label>
        <mixed-citation publication-type="journal"><name><surname>Ferenczi</surname><given-names>EA</given-names></name>, <name><surname>Zalocusky</surname><given-names>KA</given-names></name>, <name><surname>Liston</surname><given-names>C</given-names></name>, <name><surname>Grosenick</surname><given-names>L</given-names></name>, <name><surname>Warden</surname><given-names>MR</given-names></name>, <name><surname>Amatya</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>Prefrontal cortical regulation of brainwide circuit dynamics and reward-related behavior</article-title>. <source>Science</source>. <year>2016</year>;<volume>351</volume>(<issue>6268</issue>):<fpage>aac9698</fpage>
<pub-id pub-id-type="doi">10.1126/science.aac9698</pub-id>
<pub-id pub-id-type="pmid">26722001</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref053">
        <label>53</label>
        <mixed-citation publication-type="journal"><name><surname>Hallford</surname><given-names>DJ</given-names></name>, <name><surname>Sharma</surname><given-names>MK</given-names></name>. <article-title>Anticipatory pleasure for future experiences in schizophrenia spectrum disorders and major depression: A systematic review and meta-analysis</article-title>. <source>Br J Clin Psychol</source>. <year>2019</year>;<volume>58</volume>(<issue>4</issue>):<fpage>357</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1111/bjc.12218</pub-id> .<pub-id pub-id-type="pmid">30854671</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref054">
        <label>54</label>
        <mixed-citation publication-type="journal"><name><surname>Kollias</surname><given-names>CT</given-names></name>, <name><surname>Kontaxakis</surname><given-names>VP</given-names></name>, <name><surname>Havaki-Kontaxaki</surname><given-names>BJ</given-names></name>, <name><surname>Stamouli</surname><given-names>S</given-names></name>, <name><surname>Margariti</surname><given-names>M</given-names></name>, <name><surname>Petridou</surname><given-names>E</given-names></name>. <article-title>Association of physical and social anhedonia with depression in the acute phase of schizophrenia</article-title>. <source>Psychopathology</source>. <year>2008</year>;<volume>41</volume>(<issue>6</issue>):<fpage>365</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1159/000152378</pub-id> .<pub-id pub-id-type="pmid">18765962</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref055">
        <label>55</label>
        <mixed-citation publication-type="journal"><name><surname>Marder</surname><given-names>SR</given-names></name>, <name><surname>Galderisi</surname><given-names>S</given-names></name>. <article-title>The current conceptualization of negative symptoms in schizophren</article-title>ia. <source>World Psychiatry</source>. <year>2017</year>;<volume>16</volume>(<issue>1</issue>):<fpage>14</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1002/wps.20385</pub-id>
<pub-id pub-id-type="pmid">28127915</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref056">
        <label>56</label>
        <mixed-citation publication-type="journal"><name><surname>Spano</surname><given-names>MC</given-names></name>, <name><surname>Lorusso</surname><given-names>M</given-names></name>, <name><surname>Pettorruso</surname><given-names>M</given-names></name>, <name><surname>Zoratto</surname><given-names>F</given-names></name>, <name><surname>Di Giuda</surname><given-names>D</given-names></name>, <name><surname>Martinotti</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Anhedonia across borders: Transdiagnostic relevance of reward dysfunction for noninvasive brain stimulation endophenotypes</article-title>. <source>CNS Neurosci Ther</source>. <year>2019</year>
<pub-id pub-id-type="doi">10.1111/cns.13230</pub-id> .<pub-id pub-id-type="pmid">31638332</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref057">
        <label>57</label>
        <mixed-citation publication-type="journal"><name><surname>Yahata</surname><given-names>N</given-names></name>, <name><surname>Kasai</surname><given-names>K</given-names></name>, <name><surname>Kawato</surname><given-names>M</given-names></name>. <article-title>Computational neuroscience approach to biomarkers and treatments for mental disorders</article-title>. <source>Psychiatry Clin Neurosci</source>. <year>2017</year>;<volume>71</volume>(<issue>4</issue>):<fpage>215</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1111/pcn.12502</pub-id> .<pub-id pub-id-type="pmid">28032396</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref058">
        <label>58</label>
        <mixed-citation publication-type="journal"><name><surname>Yamada</surname><given-names>T</given-names></name>, <name><surname>Hashimoto</surname><given-names>RI</given-names></name>, <name><surname>Yahata</surname><given-names>N</given-names></name>, <name><surname>Ichikawa</surname><given-names>N</given-names></name>, <name><surname>Yoshihara</surname><given-names>Y</given-names></name>, <name><surname>Okamoto</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Resting-State Functional Connectivity-Based Biomarkers and Functional MRI-Based Neurofeedback for Psychiatric Disorders: A Challenge for Developing Theranostic Biomarkers</article-title>. <source>Int J Neuropsychopharmacol</source>. <year>2017</year>;<volume>20</volume>(<issue>10</issue>):<fpage>769</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1093/ijnp/pyx059</pub-id>
<pub-id pub-id-type="pmid">28977523</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref059">
        <label>59</label>
        <mixed-citation publication-type="journal"><name><surname>Koush</surname><given-names>Y</given-names></name>, <name><surname>Meskaldji</surname><given-names>DE</given-names></name>, <name><surname>Pichon</surname><given-names>S</given-names></name>, <name><surname>Rey</surname><given-names>G</given-names></name>, <name><surname>Rieger</surname><given-names>SW</given-names></name>, <name><surname>Linden</surname><given-names>DE</given-names></name>, <etal>et al</etal>
<article-title>Learning Control Over Emotion Networks Through Connectivity-Based Neurofeedback</article-title>. <source>Cereb Cortex</source>. <year>2017</year>;<volume>27</volume>(<issue>2</issue>):<fpage>1193</fpage>–<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhv311</pub-id> .<pub-id pub-id-type="pmid">26679192</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref060">
        <label>60</label>
        <mixed-citation publication-type="journal"><name><surname>Megumi</surname><given-names>F</given-names></name>, <name><surname>Yamashita</surname><given-names>A</given-names></name>, <name><surname>Kawato</surname><given-names>M</given-names></name>, <name><surname>Imamizu</surname><given-names>H</given-names></name>. <article-title>Functional MRI neurofeedback training on connectivity between two regions induces long-lasting changes in intrinsic functional network</article-title>. <source>Front Hum Neurosci</source>. <year>2015</year>;<volume>9</volume>:<fpage>160</fpage>
<pub-id pub-id-type="doi">10.3389/fnhum.2015.00160</pub-id>
<pub-id pub-id-type="pmid">25870552</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref061">
        <label>61</label>
        <mixed-citation publication-type="journal"><name><surname>Yamashita</surname><given-names>A</given-names></name>, <name><surname>Hayasaka</surname><given-names>S</given-names></name>, <name><surname>Kawato</surname><given-names>M</given-names></name>, <name><surname>Imamizu</surname><given-names>H</given-names></name>. <article-title>Connectivity Neurofeedback Training Can Differentially Change Functional Connectivity and Cognitive Performance</article-title>. <source>Cereb Cortex</source>. <year>2017</year>;<volume>27</volume>(<issue>10</issue>):<fpage>4960</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhx177</pub-id>
<pub-id pub-id-type="pmid">28922830</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref062">
        <label>62</label>
        <mixed-citation publication-type="journal"><name><surname>Esteban</surname><given-names>O</given-names></name>, <name><surname>Markiewicz</surname><given-names>CJ</given-names></name>, <name><surname>Blair</surname><given-names>RW</given-names></name>, <name><surname>Moodie</surname><given-names>CA</given-names></name>, <name><surname>Isik</surname><given-names>AI</given-names></name>, <name><surname>Erramuzpe</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>fMRIPrep: a robust preprocessing pipeline for functional MRI</article-title>. <source>Nature Methods</source>. <year>2019</year>;<volume>16</volume>(<issue>1</issue>):<fpage>111</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/s41592-018-0235-4</pub-id>
<pub-id pub-id-type="pmid">30532080</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref063">
        <label>63</label>
        <mixed-citation publication-type="journal"><name><surname>Dickie</surname><given-names>EW</given-names></name>, <name><surname>Anticevic</surname><given-names>A</given-names></name>, <name><surname>Smith</surname><given-names>DE</given-names></name>, <name><surname>Coalson</surname><given-names>TS</given-names></name>, <name><surname>Manogaran</surname><given-names>M</given-names></name>, <name><surname>Calarco</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>ciftify: A framework for surface-based analysis of legacy MR acquisitions</article-title>. <source>bioRxiv</source>. <year>2019</year>:<fpage>484428</fpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2019.04.078</pub-id>
<pub-id pub-id-type="pmid">31091476</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref064">
        <label>64</label>
        <mixed-citation publication-type="journal"><name><surname>Tzourio-Mazoyer</surname><given-names>N</given-names></name>, <name><surname>Landeau</surname><given-names>B</given-names></name>, <name><surname>Papathanassiou</surname><given-names>D</given-names></name>, <name><surname>Crivello</surname><given-names>F</given-names></name>, <name><surname>Etard</surname><given-names>O</given-names></name>, <name><surname>Delcroix</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain</article-title>. <source>Neuroimage</source>. <year>2002</year>;<volume>15</volume>(<issue>1</issue>):<fpage>273</fpage>–<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1006/nimg.2001.0978</pub-id> .<pub-id pub-id-type="pmid">11771995</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref065">
        <label>65</label>
        <mixed-citation publication-type="journal"><name><surname>Behzadi</surname><given-names>Y</given-names></name>, <name><surname>Restom</surname><given-names>K</given-names></name>, <name><surname>Liau</surname><given-names>J</given-names></name>, <name><surname>Liu</surname><given-names>TT</given-names></name>. <article-title>A component based noise correction method (CompCor) for BOLD and perfusion based fMRI</article-title>. <source>Neuroimage</source>. <year>2007</year>;<volume>37</volume>(<issue>1</issue>):<fpage>90</fpage>–<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2007.04.042</pub-id>
<pub-id pub-id-type="pmid">17560126</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref066">
        <label>66</label>
        <mixed-citation publication-type="journal"><name><surname>Ciric</surname><given-names>R</given-names></name>, <name><surname>Wolf</surname><given-names>DH</given-names></name>, <name><surname>Power</surname><given-names>JD</given-names></name>, <name><surname>Roalf</surname><given-names>DR</given-names></name>, <name><surname>Baum</surname><given-names>GL</given-names></name>, <name><surname>Ruparel</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>Benchmarking of participant-level confound regression strategies for the control of motion artifact in studies of functional connectivity</article-title>. <source>Neuroimage</source>. <year>2017</year>;<volume>154</volume>:<fpage>174</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2017.03.020</pub-id>
<pub-id pub-id-type="pmid">28302591</pub-id></mixed-citation>
      </ref>
      <ref id="pbio.3000966.ref067">
        <label>67</label>
        <mixed-citation publication-type="journal"><name><surname>Power</surname><given-names>JD</given-names></name>, <name><surname>Mitra</surname><given-names>A</given-names></name>, <name><surname>Laumann</surname><given-names>TO</given-names></name>, <name><surname>Snyder</surname><given-names>AZ</given-names></name>, <name><surname>Schlaggar</surname><given-names>BL</given-names></name>, <name><surname>Petersen</surname><given-names>SE</given-names></name>. <article-title>Methods to detect, characterize, and remove motion artifact in resting state fMRI</article-title>. <source>Neuroimage</source>. <year>2014</year>;<volume>84</volume>:<fpage>320</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2013.08.048</pub-id>
<pub-id pub-id-type="pmid">23994314</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article id="pbio.3000966.r001" article-type="editor-report">
    <front-stub>
      <article-id pub-id-type="doi">10.1371/journal.pbio.3000966.r001</article-id>
      <title-group>
        <article-title>Decision Letter 0</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Gasque</surname>
            <given-names>Gabriel</given-names>
          </name>
          <role>Senior Editor</role>
        </contrib>
      </contrib-group>
      <permissions>
        <copyright-statement>© 2020 Gabriel Gasque</copyright-statement>
        <copyright-year>2020</copyright-year>
        <copyright-holder>Gabriel Gasque</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <related-article id="rel-obj001" ext-link-type="doi" xlink:href="10.1371/journal.pbio.3000966" related-article-type="reviewed-article"/>
      <custom-meta-group>
        <custom-meta>
          <meta-name>Submission Version</meta-name>
          <meta-value>0</meta-value>
        </custom-meta>
      </custom-meta-group>
    </front-stub>
    <body>
      <p>
<named-content content-type="letter-date">22 Apr 2020</named-content>
</p>
      <p>Dear Dr Yamashita, </p>
      <p>Thank you for submitting your manuscript entitled "Generalizable brain network markers of major depressive disorder across multiple imaging sites" for consideration as a Research Article by PLOS Biology.</p>
      <p>Your manuscript has now been evaluated by the PLOS Biology editorial staff, as well as by an Academic Editor with relevant expertise, and I am writing to let you know that we would like to send your submission out for external peer review.</p>
      <p>However, before we can send your manuscript to reviewers, we need you to complete your submission by providing the metadata that is required for full assessment. To this end, please login to Editorial Manager where you will find the paper in the 'Submissions Needing Revisions' folder on your homepage. Please click 'Revise Submission' from the Action Links and complete all additional questions in the submission questionnaire.</p>
      <p>Please re-submit your manuscript within two working days, i.e. by Apr 24 2020 11:59PM.</p>
      <p>Login to Editorial Manager here: <ext-link ext-link-type="uri" xlink:href="https://www.editorialmanager.com/pbiology">https://www.editorialmanager.com/pbiology</ext-link>
</p>
      <p>During resubmission, you will be invited to opt-in to posting your pre-review manuscript as a bioRxiv preprint. Visit <ext-link ext-link-type="uri" xlink:href="http://journals.plos.org/plosbiology/s/preprints">http://journals.plos.org/plosbiology/s/preprints</ext-link> for full details. If you consent to posting your current manuscript as a preprint, please upload a single Preprint PDF when you re-submit. </p>
      <p>Once your full submission is complete, your paper will undergo a series of checks in preparation for peer review. Once your manuscript has passed all checks it will be sent out for review. </p>
      <p>Given the disruptions resulting from the ongoing COVID-19 pandemic, please expect delays in the editorial process. We apologise in advance for any inconvenience caused and will do our best to minimize impact as far as possible.</p>
      <p>Feel free to email us at <email>plosbiology@plos.org</email> if you have any queries relating to your submission.</p>
      <p>Kind regards,</p>
      <p>Gabriel Gasque, Ph.D.,</p>
      <p>Senior Editor</p>
      <p>PLOS Biology</p>
    </body>
  </sub-article>
  <sub-article id="pbio.3000966.r002" article-type="aggregated-review-documents">
    <front-stub>
      <article-id pub-id-type="doi">10.1371/journal.pbio.3000966.r002</article-id>
      <title-group>
        <article-title>Decision Letter 1</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Gasque</surname>
            <given-names>Gabriel</given-names>
          </name>
          <role>Senior Editor</role>
        </contrib>
      </contrib-group>
      <permissions>
        <copyright-statement>© 2020 Gabriel Gasque</copyright-statement>
        <copyright-year>2020</copyright-year>
        <copyright-holder>Gabriel Gasque</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <related-article id="rel-obj002" ext-link-type="doi" xlink:href="10.1371/journal.pbio.3000966" related-article-type="reviewed-article"/>
      <custom-meta-group>
        <custom-meta>
          <meta-name>Submission Version</meta-name>
          <meta-value>1</meta-value>
        </custom-meta>
      </custom-meta-group>
    </front-stub>
    <body>
      <p>
<named-content content-type="letter-date">4 Jun 2020</named-content>
</p>
      <p>Dear Dr Yamashita,</p>
      <p>Thank you very much for submitting your manuscript "Generalizable brain network markers of major depressive disorder across multiple imaging sites" for consideration as a Research Article at PLOS Biology. Your manuscript has been evaluated by the PLOS Biology editors, by an Academic Editor with relevant expertise, and by three independent reviewers. You will note that reviewer 3, A. Vania Apkarian, has signed his comments. </p>
      <p>In light of the reviews (below), we will not be able to accept the current version of the manuscript, but we would welcome re-submission of a much-revised version that takes into account the reviewers' comments. We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent for further evaluation by the reviewers.</p>
      <p>We expect to receive your revised manuscript within 2 months. </p>
      <p>Please email us (<email>plosbiology@plos.org</email>) if you have any questions or concerns, or would like to request an extension. At this stage, your manuscript remains formally under active consideration at our journal; please notify us by email if you do not intend to submit a revision so that we may end consideration of the manuscript at PLOS Biology.</p>
      <p>**IMPORTANT - SUBMITTING YOUR REVISION**</p>
      <p>Your revisions should address the specific points made by each reviewer. As you will see, while there is overall enthusiasm by the reviewers, reviewers 1 and 2 agree, although with slightly different tones, that lumping depression as a single diagnostic entity is not correct/useful and that you should try to identify different subgroups/MDD dimensions. In addition, reviewer 3 thinks that several additional analyses are needed to support your claims. Having discussed the comments with the Academic Editor, we do not think you should change the whole approach - but exploring subgroups and correlations with BDI are useful suggestions. We also think that it might be helpful to test some of the Drysdale et al. cohorts (reviewer 3). However, we also appreciate a limitation in the sense that the datasets across the two papers are no longer independent. We would leave it to you to decide how to proceed here.</p>
      <p>Independently, the Academic Editor points to two methodological concerns which should be addressed: </p>
      <p>1) how can harmonization be applied to independent test cohorts without information leakage? What would be the procedure for applying this data prospectively to new cohorts? </p>
      <p>2) can you rule out the possibility that the classifier's performance is driven by confounds, particularly head movement? One approach is to test whether classifier scores (i.e., probability of depression) can be predicted from combinations of head movement parameters (e.g., as in Kohoutova et al. 2020, Nat. Protocols).</p>
      <p>Please submit the following files along with your revised manuscript:</p>
      <p>1. A 'Response to Reviewers' file - this should detail your responses to the editorial requests, present a point-by-point response to all of the reviewers' comments, and indicate the changes made to the manuscript.</p>
      <p>*NOTE: In your point by point response to the reviewers, please provide the full context of each review. Do not selectively quote paragraphs or sentences to reply to. The entire set of reviewer comments should be present in full and each specific point should be responded to individually, point by point.</p>
      <p>You should also cite any additional relevant literature that has been published since the original submission and mention any additional citations in your response. </p>
      <p>2. In addition to a clean copy of the manuscript, please also upload a 'track-changes' version of your manuscript that specifies the edits made. This should be uploaded as a "Related" file type. </p>
      <p>*Re-submission Checklist*</p>
      <p>When you are ready to resubmit your revised manuscript, please refer to this re-submission checklist: <ext-link ext-link-type="uri" xlink:href="https://plos.io/Biology_Checklist">https://plos.io/Biology_Checklist</ext-link></p>
      <p>To submit a revised version of your manuscript, please go to <ext-link ext-link-type="uri" xlink:href="https://www.editorialmanager.com/pbiology/">https://www.editorialmanager.com/pbiology/</ext-link> and log in as an Author. Click the link labelled 'Submissions Needing Revision' where you will find your submission record. </p>
      <p>Please make sure to read the following important policies and guidelines while preparing your revision:</p>
      <p>*Published Peer Review*</p>
      <p>Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/">https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/</ext-link>
      </p>
      <p>*PLOS Data Policy*</p>
      <p>Please note that as a condition of publication PLOS' data policy (<ext-link ext-link-type="uri" xlink:href="http://journals.plos.org/plosbiology/s/data-availability">http://journals.plos.org/plosbiology/s/data-availability</ext-link>) requires that you make available all data used to draw the conclusions arrived at in your manuscript. If you have not already done so, you must include any data used in your manuscript either in appropriate repositories, within the body of the manuscript, or as supporting information (N.B. this includes any numerical values that were used to generate graphs, histograms etc.). For an example see here: <ext-link ext-link-type="uri" xlink:href="http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5">http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5</ext-link>
</p>
      <p>*Blot and Gel Data Policy*</p>
      <p>We require the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article's figures or Supporting Information files. We will require these files before a manuscript can be accepted so please prepare them now, if you have not already uploaded them. Please carefully read our guidelines for how to prepare and upload this data: <ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements">https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements</ext-link>
</p>
      <p>*Protocols deposition*</p>
      <p>To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosbiology/s/submission-guidelines#loc-materials-and-methods">https://journals.plos.org/plosbiology/s/submission-guidelines#loc-materials-and-methods</ext-link>
</p>
      <p>Thank you again for your submission to our journal. We hope that our editorial process has been constructive thus far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.</p>
      <p>Sincerely,</p>
      <p>Gabriel Gasque, Ph.D., </p>
      <p>Senior Editor</p>
      <p>PLOS Biology</p>
      <p>*****************************************************</p>
      <p>REVIEWS:</p>
      <p>Academic Editor:</p>
      <p>1) how can harmonization be applied to independent test cohorts without information leakage? What would be the procedure for applying this data prospectively to new cohorts? </p>
      <p>2) can you rule out the possibility that the classifier's performance is driven by confounds, particularly head movement? One approach is to test whether classifier scores (i.e., probability of depression) can be predicted from combinations of head movement parameters (e.g., as in Kohoutova et al. 2020, Nat. Protocols).</p>
      <p>Reviewer #1: This interesting study aimed to examine the utility of a method designed to remove site differences in resting state functional connectivity datasets when aiming to identify a classifier distinguishing patients with major depressive disorder (MDD) from healthy controls. The authors report a 69% accuracy in distinguishing the two groups the classifier in an independent dataset. The authors used another dataset of healthy, schizophrenic and ASD patients to determine the specificity of the classifier, and showed that the classifier generalized to schizophrenia but not ASD.</p>
      <p>The major strength of the paper is the large number of participants in the discovery dataset and the use of a large, independent dataset for classifier testing. Additional strengths were the that both discovery and testing cohorts comprised data from multiple sites, and the use of a "traveling participant" subgroup to allow assessment of measurement bias across the different sites in the discovery dataset.</p>
      <p>The methodology appears to be sound, using established techniques, as well as a novel harmonization method.</p>
      <p>I have some points requiring clarification.</p>
      <p>A main point is that it is unclear as to how significant the 69% classification accuracy actually is for differentiating between MDD patients and healthy controls in clinical practice, given the relative ease at distinguishing patients with MDD from healthy controls clinically. A potentially more useful classification would be to identify different subgroups/ MDDD dimensions.</p>
      <p>It is not clear how systematically patient medication status was considered in sensitivity analyses examining the generalizability of the classifier to milder versus more severe depression (p.9).</p>
      <p>Was the undersampling procedure in the discovery dataset analyses adequate to control for the fact that the number of patients with MDD was 4 x smaller than that of healthy controls?</p>
      <p>There is no description of the nature of the main FC profiles important for classifying MDD in the Results. Similarly, it is only In the Discussion that the authors note findings regarding schizophrenia and ASD patient analyses. It would be helpful to have brief summary of these important findings in the Results section.</p>
      <p>Reviewer #2: I previously reviewed this paper for the other journal (Nat Comms). I found the authors have made additional changes since then. The biggest change I noticed is that they removed the BDI regression model. Also they changed their emphasis from "common brain networks between the classification and regression model" to "generalizable brain markers of MDD". These changes resolved many issues I previously raised, which were related to information leakage and the stability of the feature selection. Given that these problems were among my major concerns in previous reviews, the current version of manuscript seems better than the previous one, but I still find a couple of issues in the current manuscript, though this study certainly has some strengths, including its large sample size collected from multiple sites (N = 1,162; 334 MDD patients) and having a validation set to obtain unbiased estimates of the model performance and its generalizability. </p>
      <p>First, though they started the paper with explaining the RDoC initiative, they still treat the depression as a single diagnostic entity. This lumping approach has been criticized since early 2000 (Hyman, 2008, Nature; Miller, 2010, Science) and the criticism regarding the lumping approach provided the biggest motivation for the RDoC initiative. Depression is a highly heterogeneous condition (Insel &amp; Cuthbert, 2015, Science), and therefore with this type of simple MDD vs. HC classifier, it is difficult to know what the model really captures because the MDD as a whole can mean many different things. They suggested that their model captures the MDD-ness and also anhedonia that is common across MDD and SCZ, but it struck me that the generalization to SCZ not to ASD is not enough to justify this "anhedonia" interpretation because SCZ and MDD shares many features other than anhedonia (e.g., Borsboom &amp; Cramer, 2013). </p>
      <p>Second, in the previous revision, the classification performance for ASD was also significant (p = 2.0 * 10^-7; this is the quote from the previous manuscript, "The separation between ASD individuals and their healthy controls was poorer than that of SCZ but statistically significant (Fig. 8c; AUC = 0.57). "), and I wonder what has been changed since then. One change I noticed that in the previous paper, they reported the AUC, but in the current manuscript, they reported only the accuracy. Considering that this change (sig -&gt; non-sig for ASD classification) seems important for the functional interpretation of the model, the authors should clarify what has been changed and whether the changes can be justified. </p>
      <p>Reviewer #3, A. Vania Apkarian: This is a well executed study hoping to identify resting state fMRI signal that can have utility in identifying subjects with depression. The authors use a large data set from multiple centers, and perform well-organized discovery and validation approach, where the validation data come from separate sources than those used in the discovery. In general the results seem convincing and the author put effort in quantifying the extent to which observed result can be translated to the clinic. There are also important issues that need to be addressed:</p>
      <p>1) The paper extensively discusses the utility harmonizing rating state data across different centers. The effect size of this procedure remains unclear and needs to be demonstrated. There is a second worry along this line. The harmonization correction used for discovery and validation data were not the same. How this difference effects outcomes need also further clarification. </p>
      <p>2) There is no evidence that the authors corrected for age and gender influences on FC values. Both of these are well known modulators of FC and the various data sets used in the study are slightly different on these parameters. One wonders if predictability would improve once such influences are corrected for. It is also likely that age and gender themselves influence on head motion. At least the extent of head motion contribution to predictability needs to be identified, with/without age gender effects.</p>
      <p>3) The discovery and validation approach is very good. However, it is all based on data collected in Japan. The results would be more convincing if they can generalize to data collected in other centers. Perhaps the authors can test some of the Drysdale data that is publicly available. This is specially important as the discussion mentions that some of the specific links are shared between them and Drysdale.</p>
      <p>4) The parcellation scheme used seems unique to the group. It would be nice if higher/lower resolution parcellations can also be tested. This would address the extent to which observed results are robust and independent of the specifics of parcellation.</p>
      <p>5) Head motion remains a main worry in constructing FC matrices. It would be nice to show that resultant matrices were NOT or minimally affected by head motion.</p>
      <p>6) Although the authors claim to use independent discovery and validation data sets. It is not always clear that this separation was properly followed. Please indicate more clearly when it was or was not.</p>
      <p>7) Obtained results would be further strengthened if identified links or some subset of them actually tracked the primary variable on which the data are being separated: BDI scale. </p>
      <p>Overall, the paper is a very good effort but can be further clarified and needs additional analysis to convince the reader of all the their claims.</p>
    </body>
  </sub-article>
  <sub-article id="pbio.3000966.r003" article-type="author-comment">
    <front-stub>
      <article-id pub-id-type="doi">10.1371/journal.pbio.3000966.r003</article-id>
      <title-group>
        <article-title>Author response to Decision Letter 1</article-title>
      </title-group>
      <related-article id="rel-obj003" ext-link-type="doi" xlink:href="10.1371/journal.pbio.3000966" related-article-type="editor-report"/>
      <custom-meta-group>
        <custom-meta>
          <meta-name>Submission Version</meta-name>
          <meta-value>2</meta-value>
        </custom-meta>
      </custom-meta-group>
    </front-stub>
    <body>
      <p>
<named-content content-type="author-response-date">3 Aug 2020</named-content>
</p>
      <supplementary-material content-type="local-data" id="pbio.3000966.s019">
        <label>Attachment</label>
        <caption>
          <p>Submitted filename: <named-content content-type="submitted-filename">ResponseLetter_PLOSBiology_R1.docx</named-content></p>
        </caption>
        <media xlink:href="pbio.3000966.s019.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </body>
  </sub-article>
  <sub-article id="pbio.3000966.r004" article-type="aggregated-review-documents">
    <front-stub>
      <article-id pub-id-type="doi">10.1371/journal.pbio.3000966.r004</article-id>
      <title-group>
        <article-title>Decision Letter 2</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Gasque</surname>
            <given-names>Gabriel</given-names>
          </name>
          <role>Senior Editor</role>
        </contrib>
      </contrib-group>
      <permissions>
        <copyright-statement>© 2020 Gabriel Gasque</copyright-statement>
        <copyright-year>2020</copyright-year>
        <copyright-holder>Gabriel Gasque</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <related-article id="rel-obj004" ext-link-type="doi" xlink:href="10.1371/journal.pbio.3000966" related-article-type="reviewed-article"/>
      <custom-meta-group>
        <custom-meta>
          <meta-name>Submission Version</meta-name>
          <meta-value>2</meta-value>
        </custom-meta>
      </custom-meta-group>
    </front-stub>
    <body>
      <p>
<named-content content-type="letter-date">7 Oct 2020</named-content>
</p>
      <p>Dear Dr Yamashita,</p>
      <p>Thank you for submitting your revised Research Article entitled "Generalizable brain network markers of major depressive disorder across multiple imaging sites" for publication in PLOS Biology. I have now obtained advice from the original reviewers and have discussed their comments with the Academic Editor. You will note that reviewer 3, Apkar Vania Apkarian, has revealed his identity. Please accept my apologies for the delay in sending the decision below to you.</p>
      <p>Based on the reviews, we will probably accept this manuscript for publication, assuming that you will modify the manuscript to address the remaining points raised by reviewer1. Please also make sure to address the data and other policy-related requests noted at the end of this email.</p>
      <p>We expect to receive your revised manuscript within two weeks. Your revisions should address the specific points made by each reviewer. In addition to the remaining revisions and before we will be able to formally accept your manuscript and consider it "in press", we also need to ensure that your article conforms to our guidelines. A member of our team will be in touch shortly with a set of requests. As we can't proceed until these requirements are met, your swift response will help prevent delays to publication.</p>
      <p>To submit your revision, please go to <ext-link ext-link-type="uri" xlink:href="https://www.editorialmanager.com/pbiology/">https://www.editorialmanager.com/pbiology/</ext-link> and log in as an Author. Click the link labelled 'Submissions Needing Revision' to find your submission record. Your revised submission must include the following:</p>
      <p>- a cover letter that should detail your responses to any editorial requests, if applicable</p>
      <p>- a Response to Reviewers file that provides a detailed response to the reviewers' comments (if applicable)</p>
      <p>- a track-changes file indicating any changes that you have made to the manuscript. </p>
      <p>*Copyediting*</p>
      <p>Upon acceptance of your article, your final files will be copyedited and typeset into the final PDF. While you will have an opportunity to review these files as proofs, PLOS will only permit corrections to spelling or significant scientific errors. Therefore, please take this final revision time to assess and make any remaining major changes to your manuscript.</p>
      <p>NOTE: If Supporting Information files are included with your article, note that these are not copyedited and will be published as they are submitted. Please ensure that these files are legible and of high quality (at least 300 dpi) in an easily accessible file format. For this reason, please be aware that any references listed in an SI file will not be indexed. For more information, see our Supporting Information guidelines:</p>
      <p><ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosbiology/s/supporting-information">https://journals.plos.org/plosbiology/s/supporting-information</ext-link>
</p>
      <p>*Published Peer Review History*</p>
      <p>Please note that you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/">https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/</ext-link>
      </p>
      <p>*Early Version*</p>
      <p>Please note that an uncorrected proof of your manuscript will be published online ahead of the final version, unless you opted out when submitting your manuscript. If, for any reason, you do not want an earlier version of your manuscript published online, uncheck the box. Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us as soon as possible if you or your institution is planning to press release the article.</p>
      <p>*Protocols deposition*</p>
      <p>To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosbiology/s/submission-guidelines#loc-materials-and-methods">https://journals.plos.org/plosbiology/s/submission-guidelines#loc-materials-and-methods</ext-link>
</p>
      <p>Please do not hesitate to contact me should you have any questions.</p>
      <p>Sincerely,</p>
      <p>Gabriel Gasque, Ph.D.,</p>
      <p>Senior Editor,</p>
      <p><email>ggasque@plos.org</email>,</p>
      <p>PLOS Biology</p>
      <p>------------------------------------------------------------------------</p>
      <p>DATA POLICY:</p>
      <p>-- Please label panel b in Fig 4.</p>
      <p>-- Please check your S1 Data file because you include that for Figure 4c, but there’s no panel c in Figure 4.</p>
      <p>-- Please provide data for Figure 5bc. </p>
      <p>-- Please include the X-axis values for data for Fig S1. </p>
      <p>-- Please also ensure that each figure legend in your manuscript includes information on where the underlying data can be found (S1 Data).</p>
      <p>------------------------------------------------------------------------</p>
      <p>Reviewer remarks:</p>
      <p>Reviewer #1: The authors have responded very comprehensively to my previous comments on this paper. I would still maintain, however, that distinguishing between MDD and healthy status in clinical practice is straightforward for an experienced clinician. The utility of having a biological marker is to understand underlying pathophysiological mechanisms of illness to guide treatment choice and the future development of novel interventions for a given disorder. The authors should highlight this in the Introduction of the paper.</p>
      <p>Reviewer #2: The authors have addressed my comments satisfactorily. </p>
      <p>Reviewer #3: The authors have properly addressed all issues raised by all reviewers. They comprehensively address a long list of questions and incorporate the issues in the introduction and discussion, and properly report all new results either in the main body or in the extensive supplements.</p>
    </body>
  </sub-article>
  <sub-article id="pbio.3000966.r005" article-type="author-comment">
    <front-stub>
      <article-id pub-id-type="doi">10.1371/journal.pbio.3000966.r005</article-id>
      <title-group>
        <article-title>Author response to Decision Letter 2</article-title>
      </title-group>
      <related-article id="rel-obj005" ext-link-type="doi" xlink:href="10.1371/journal.pbio.3000966" related-article-type="editor-report"/>
      <custom-meta-group>
        <custom-meta>
          <meta-name>Submission Version</meta-name>
          <meta-value>3</meta-value>
        </custom-meta>
      </custom-meta-group>
    </front-stub>
    <body>
      <p>
<named-content content-type="author-response-date">27 Oct 2020</named-content>
</p>
      <supplementary-material content-type="local-data" id="pbio.3000966.s020">
        <label>Attachment</label>
        <caption>
          <p>Submitted filename: <named-content content-type="submitted-filename">ResponseLetter_PLOSBiology.docx</named-content></p>
        </caption>
        <media xlink:href="pbio.3000966.s020.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </body>
  </sub-article>
  <sub-article id="pbio.3000966.r006" article-type="editor-report">
    <front-stub>
      <article-id pub-id-type="doi">10.1371/journal.pbio.3000966.r006</article-id>
      <title-group>
        <article-title>Decision Letter 3</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Gasque</surname>
            <given-names>Gabriel</given-names>
          </name>
          <role>Senior Editor</role>
        </contrib>
      </contrib-group>
      <permissions>
        <copyright-statement>© 2020 Gabriel Gasque</copyright-statement>
        <copyright-year>2020</copyright-year>
        <copyright-holder>Gabriel Gasque</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <related-article id="rel-obj006" ext-link-type="doi" xlink:href="10.1371/journal.pbio.3000966" related-article-type="reviewed-article"/>
      <custom-meta-group>
        <custom-meta>
          <meta-name>Submission Version</meta-name>
          <meta-value>3</meta-value>
        </custom-meta>
      </custom-meta-group>
    </front-stub>
    <body>
      <p>
<named-content content-type="letter-date">2 Nov 2020</named-content>
</p>
      <p>Dear Dr Yamashita,</p>
      <p>On behalf of my colleagues and the Academic Editor, Tor D. Wager, I am pleased to inform you that we will be delighted to publish your Research Article in PLOS Biology. </p>
      <p>PRODUCTION PROCESS</p>
      <p>Before publication you will see the copyedited word document (within 5 business days) and a PDF proof shortly after that. The copyeditor will be in touch shortly before sending you the copyedited Word document. We will make some revisions at copyediting stage to conform to our general style, and for clarification. When you receive this version you should check and revise it very carefully, including figures, tables, references, and supporting information, because corrections at the next stage (proofs) will be strictly limited to (1) errors in author names or affiliations, (2) errors of scientific fact that would cause misunderstandings to readers, and (3) printer's (introduced) errors. Please return the copyedited file within 2 business days in order to ensure timely delivery of the PDF proof. </p>
      <p>If you are likely to be away when either this document or the proof is sent, please ensure we have contact information of a second person, as we will need you to respond quickly at each point. Given the disruptions resulting from the ongoing COVID-19 pandemic, there may be delays in the production process. We apologise in advance for any inconvenience caused and will do our best to minimize impact as far as possible.</p>
      <p>EARLY VERSION</p>
      <p>The version of your manuscript submitted at the copyedit stage will be posted online ahead of the final proof version, unless you have already opted out of the process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.</p>
      <p>PRESS </p>
      <p>We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with <email>biologypress@plos.org</email>. If you have not yet opted out of the early version process, we ask that you notify us immediately of any press plans so that we may do so on your behalf.</p>
      <p>We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit <ext-link ext-link-type="uri" xlink:href="http://www.plos.org/about/media-inquiries/embargo-policy/">http://www.plos.org/about/media-inquiries/embargo-policy/</ext-link>.</p>
      <p>Thank you again for submitting your manuscript to PLOS Biology and for your support of Open Access publishing. Please do not hesitate to contact me if I can provide any assistance during the production process.</p>
      <p>Kind regards,</p>
      <p>Alice Musson</p>
      <p>Publishing Editor, </p>
      <p>PLOS Biology</p>
      <p>on behalf of</p>
      <p>Gabriel Gasque,</p>
      <p>Senior Editor</p>
      <p>PLOS Biology</p>
    </body>
  </sub-article>
</article>
